This article provides a comprehensive guide for researchers and drug development professionals on identifying materials with high synthesis feasibility—a critical step in accelerating the discovery of functional materials.
This article provides a comprehensive guide for researchers and drug development professionals on identifying materials with high synthesis feasibilityâa critical step in accelerating the discovery of functional materials. It explores the foundational principles of material stability from thermodynamic and kinetic perspectives, reviews advanced methodologies from high-pressure techniques to machine learning (ML)-assisted synthesis, and addresses common troubleshooting and optimization challenges. The content further covers validation frameworks and comparative analysis of synthesis routes, synthesizing key takeaways to outline future directions for biomedical and clinical research. By integrating computational guidance with experimental practices, this resource aims to shorten the material discovery cycle from years to months.
In material science, synthesis feasibility refers to the practical assessment of whether a proposed method for creating a new material can be successfully carried out. This evaluation encompasses multiple dimensions, from the fundamental chemistry to project management constraints [1].
A feasible synthesis pathway must demonstrate that it can produce the target material using available methods and resources, while satisfying requirements for efficiency, cost, and safety [1]. For novel inorganic compounds, this often involves specialized techniques like high-pressure synthesis, which can create unprecedented materials that remain stable under atmospheric conditions, such as high-temperature superconductors with transition temperatures up to 250 K or ultra-hard nano-diamonds [2].
A structured approach to feasibility assessment helps researchers systematically evaluate potential synthesis pathways before committing significant resources.
Adapted from public health research but applicable to material science, these domains provide a comprehensive framework for evaluation [4]:
Table 1: Feasibility Assessment Framework for Material Synthesis
| Domain | Assessment Focus | Material Science Application |
|---|---|---|
| Acceptability | Judgments of suitability, satisfaction, or attractiveness | How target users perceive the new material's properties and potential applications |
| Demand | Estimated or actual use | Potential market adoption or research application breadth |
| Implementation | Capability to execute synthesis as planned | Availability of specialized equipment (e.g., HTHP systems) and technical expertise |
| Practicality | Delivery within resource constraints | Synthesis possible with available time, budget, and personnel |
| Adaptation | Changes needed for new formats or populations | Modifications required for scaling from lab to production |
| Integration | Fit with existing systems | Compatibility with current manufacturing or research infrastructure |
| Expansion | Potential success in different contexts | Material's applicability across multiple industries or research fields |
| Limited Efficacy Testing | Promise of success under controlled conditions | Preliminary validation of material properties in lab settings |
The systems engineering approach to synthesis involves iterative activities to develop possible solutions [5]:
This workflow can be visualized as a iterative process:
Problem: Inability to Achieve Required Synthesis Conditions
Problem: Low Yield or Purity
Problem: Unstable or Highly Reactive Intermediates
Problem: Limited Access to Specialized Equipment
Problem: Scarce or Expensive Starting Materials
Understanding funding priorities helps researchers align projects with available resources and industry needs.
Table 2: Materials Discovery Investment Trends (2020 - Mid 2025) [7]
| Year | Equity Investment (USD) | Grant Funding (USD) | Key Sector Developments |
|---|---|---|---|
| 2020 | $56 million | Not specified | Early-stage research focus |
| 2023 | Not specified | $59.47 million | Infleqtion quantum technology grant: $56.8M |
| 2024 | Not specified | $149.87 million | Mitra Chem battery materials: $100M DOE grant |
| Mid-2025 | $206 million | Not specified | Growth in computational materials science |
Table 3: Investment Distribution in Materials Discovery Sub-segments [7]
| Sub-segment | Cumulative Funding (2020-2025) | Key Applications |
|---|---|---|
| Materials Discovery Applications | $1.3 billion | Decarbonization technologies |
| Computational Materials Science | $168 million (by mid-2025) | Simulation-based R&D acceleration |
| Materials Databases | $31 million (2025) | AI-enabled discovery workflows |
| Robotics for Materials Discovery | Minimal | Automated experimentation |
Table 4: Essential Research Reagents and Equipment for Synthesis Feasibility Studies
| Reagent/Equipment Category | Specific Examples | Function in Feasibility Assessment |
|---|---|---|
| High-Pressure Synthesis Systems | HTHP (High-Temperature High-Pressure) apparatus | Enables synthesis of novel inorganic compounds [2] |
| Computational Modeling Tools | DFT software, molecular dynamics simulations | Predicts material properties and reaction pathways before experimental work |
| Analytical Characterization | XRD, SEM, NMR spectroscopy [6] | Validates synthesis success and material structure |
| Custom Synthesis Services | Specialized chemical producers | Provides compounds not available commercially [3] |
| Metamaterial Fabrication Tools | 3D printing, lithography, etching systems | Creates engineered materials with properties not found in nature [8] |
Q1: What is the difference between technical feasibility and practical feasibility in material synthesis?
Technical feasibility addresses whether the fundamental chemical and physical processes can produce the target material, while practical feasibility considers whether the synthesis can be accomplished within real-world constraints of time, budget, and available resources [1]. A synthesis may be technically possible but practically unfeasible due to cost or safety concerns.
Q2: How do I determine if custom synthesis is preferable to using commercially available compounds?
Custom synthesis is recommended when your project requires specific structural or functional characteristics not available in commercial compounds, when working with proprietary materials, or for advanced development projects. Commercial compounds are more suitable for standard applications, budget-constrained projects, or when immediate availability is crucial [3].
Q3: What are the most common reasons for synthesis feasibility failure?
The most common failure points include: (1) unstable intermediates that cannot be isolated, (2) prohibitively expensive starting materials or equipment requirements, (3) inability to achieve required purity levels, (4) unacceptable environmental or safety impacts, and (5) time requirements that exceed project constraints [1].
Q4: How has high-pressure synthesis expanded the range of feasible materials?
High-pressure methods can create unprecedented inorganic compounds that remain stable under atmospheric conditions, including high-temperature superconductors (transition temperatures up to 250 K) and super-hard nano-diamonds with hardness approaching 1 TPa - materials that cannot be achieved through other synthetic methods [2].
Q5: What role do computational methods play in assessing synthesis feasibility?
Computational materials science has seen steady investment growth, reaching $168 million by mid-2025 [7]. These tools enable researchers to simulate material properties and reactions before laboratory work, significantly reducing trial-and-error experimentation and accelerating the identification of promising synthesis pathways.
Q1: Why does my catalyst, predicted to be thermodynamically stable, degrade rapidly during the oxygen evolution reaction (OER)?
Your catalyst may be thermodynamically stable at rest but encounter kinetic instability under operational conditions. High anodic potentials and corrosive oxidative environments during OER can create kinetic barriers that favor catalyst dissolution or phase transformation over stability. This is a common challenge where operational kinetics override thermodynamic predictions [9].
Q2: How can I quickly assess if a material with high thermodynamic stability has impractically slow reaction kinetics?
A key indicator is a high overpotential, particularly for the OER. A large overpotential signifies a substantial kinetic barrier that the reaction must overcome, even if it is thermodynamically favorable. Evaluate the Tafel slope; a higher slope suggests slower reaction kinetics and a more significant kinetic hindrance [9].
Q3: What are the primary causes of a high kinetic barrier in an otherwise stable catalyst material?
The main causes are often related to slow reaction pathways. This can include inadequate active site density, poor electron transfer kinetics, or strong reactant binding that leads to high activation energies and sluggish surface reaction rates [9].
Q4: My catalyst shows excellent activity but poor long-term stability. Is this a kinetic or thermodynamic issue?
This typically points to a kinetic issue. The material may be thermodynamically metastable. While initial activity is high, the system may be slowly progressing toward a more stable, but less active, state over time. This underscores the necessity of evaluating both activity and stability under realistic conditions [9].
Problem: Inconsistent Performance Metrics Between Laboratory and Pilot-Scale Reactors
| Observation | Likely Cause | Solution |
|---|---|---|
| Activity (e.g., turnover frequency) decreases at larger scale. | Mass transport limitations not present in small-scale lab setups. | Redesign catalyst structure (e.g., create porous nanostructures) to enhance reactant flow to active sites [9]. |
| Stability is lower in pilot-scale testing. | Inability to maintain potential and pH gradients at scale. | Integrate robust, conductive support materials to improve electronic conductivity and structural integrity [9]. |
Problem: Failure to Achieve Predicted Catalytic Activity
| Observation | Likely Cause | Solution |
|---|---|---|
| High overpotential for hydrogen evolution reaction (HER). | Low active site density or poor electronic conductivity. | Employ doping or heterojunction engineering to modulate the electronic structure and create more active sites [9]. |
| Tafel slope is higher than calculated. | Non-optimal adsorption energy of reaction intermediates. | Use computational modeling to screen for materials with near-optimal intermediate binding energies before synthesis [9]. |
Key Performance Indicators (KPIs) for Benchmarking Catalysts [9]
| Performance Indicator | Target for HER | Target for OER | Measurement Technique |
|---|---|---|---|
| Overpotential (at 10 mA/cm²) | < 50 mV | < 300 mV | Linear sweep voltammetry |
| Tafel Slope | < 40 mV/dec | < 60 mV/dec | Tafel plot analysis |
| Turnover Frequency (TOF) | > 1 sâ»Â¹ | > 0.1 sâ»Â¹ | Calculated from activity and active sites |
| Stability (Duration) | > 100 hours | > 100 hours | Chronopotentiometry |
| Electrochemical Surface Area (ECSA) | High relative to geometric area | High relative to geometric area | Double-layer capacitance (Cdl) |
Protocol 1: Evaluating Thermodynamic Stability via Electrochemical Potential
Objective: To assess the thermodynamic stability of a catalyst material within a specific potential window.
Materials:
Methodology:
Protocol 2: Measuring Kinetic Barriers via Tafel Analysis
Objective: To determine the kinetic barrier and rate-determining step of the HER or OER.
Materials:
Methodology:
b is the Tafel slope.
Research Reagent Solutions for Electrolytic Water Splitting [9]
| Reagent / Material | Function in Experiment |
|---|---|
| Potentiostat/Galvanostat | The core instrument for applying controlled potentials/currents and measuring the electrochemical response of the catalyst. |
| Standard Electrodes (Ag/AgCl, Hg/HgO) | Reference electrodes to provide a stable potential baseline against which the working electrode's potential is measured. |
| Nafion Binder | A common ionomer used to bind catalyst particles to the electrode substrate and facilitate proton transport. |
| High-Surface-Area Carbon Supports | Materials like Vulcan XC-72R used to disperse catalyst nanoparticles, increase electrical conductivity, and maximize the electrochemically active surface area. |
| Dopant Precursors | Chemical compounds (e.g., metal salts or heteroatom sources) used to introduce dopants into a catalyst matrix to modulate its electronic structure and improve activity. |
| NF-|EB-IN-10 | NF-|EB-IN-10, MF:C26H30N2O4, MW:434.5 g/mol |
| cis-Vitamin K1-d7 | cis-Vitamin K1-d7, MF:C31H46O2, MW:457.7 g/mol |
What is the core challenge in modern computational materials design? A significant challenge is the "generation-synthesis gap," where most computationally designed molecules cannot be synthesized in a laboratory. This limits the practical application of AI-assisted drug and material design. The core issue is that many models prioritize predicted performance (e.g., hole mobility, binding affinity) over synthetic feasibility, leading to brilliant theoretical designs that are impractical to make [10].
How can researchers rapidly identify active compounds from vast chemical libraries? Ultra-high-throughput screening (uHTS) allows for the testing of over 100,000 compounds per day. This method uses robotics, liquid handling devices, and sensitive detectors to conduct millions of tests quickly. By using assay plates with hundreds to thousands of wells, researchers can screen ultra-large "make-on-demand" virtual libraries containing billions of compounds to recognize active agents, or "hits" [11] [12] [13].
What methods exist to assess synthetic feasibility before starting lab work? Two main computational approaches are:
How can I design a peptide therapeutic with improved stability and bioavailability? Incorporating non-natural amino acids (NNAAs) into peptides is a common strategy. However, this introduces synthesis challenges. A first-of-its-kind tool called NNAA-Synth can assist by planning synthesis routes, selecting optimal orthogonal protecting groups (e.g., Fmoc for the backbone amine, tBu for the carboxylic acid), and scoring the synthetic feasibility of individual NNAAs to ensure they are SPPS-compatible [14].
Problem Description: Molecules generated by deep learning models, while theoretically high-performing, consistently fail during lab-scale synthesis due to complex or non-viable reaction pathways.
Diagnostic Steps:
Solution: Integrate synthesizability assessment directly into the generative AI pipeline. Use SA scoring as a filter or optimization objective during the molecular generation process. Tools like CMD-GEN, a structure-based generation framework, can incorporate drug-likeness and synthetic accessibility conditions to steer the model toward more feasible compounds [15].
Problem Description: High background noise or low signal differentiation in HTS leads to unreliable "hit" identification from primary biopsies or cell lines.
Diagnostic Steps:
Solution: Optimize the assay protocol to improve the signal-to-background ratio. This may involve:
Problem Description: The yield for an enzymatic synthesis reaction, such as the acylation of a natural compound, is prohibitively low for industrial application.
Diagnostic Steps:
Solution: Systematically optimize the reaction conditions. A techno-economic analysis of enzymatic puerarin myristate synthesis found that using low-toxicity solvents like tert-butanol and myristic anhydride as an acyl donor, with Novozym 435 as the catalyst, dramatically increased conversion to over 97% [16]. The table below summarizes the key parameters to troubleshoot.
Table: Key Parameters for Troubleshooting Enzymatic Synthesis
| Parameter | Common Issue | Optimization Strategy |
|---|---|---|
| Enzyme Type | Low activity/selectivity for substrate | Screen immobilized enzymes (e.g., Novozym 435, Lipozyme TL IM) [16]. |
| Solvent | Toxicity inhibits enzyme & product use | Switch to low-toxicity solvents (e.g., tert-butanol, acetone) [16]. |
| Acyl Donor | Low conversion efficiency | Use anhydrides over esters (e.g., myristic anhydride) [16]. |
| Molar Ratio | Imbalanced stoichiometry | Increase acyl donor to substrate ratio (e.g., 1:20) [16]. |
| Enzyme Loading | Insufficient catalyst | Increase concentration (e.g., 15 g/L) [16]. |
This table details key reagents and software tools essential for conducting synthesis feasibility research.
Table: Essential Reagents and Tools for Synthesis Feasibility Research
| Item Name | Function / Application | Specification Notes |
|---|---|---|
| Novozym 435 | Immobilized lipase enzyme for regioselective enzymatic acylation and synthesis. | Candida antarctica Lipase B immobilized on acrylic resin [16]. |
| Lipozyme TL IM | Immobilized lipase enzyme for enzymatic synthesis. | Thermomyces lanuginosus lipase immobilized on a silica gel carrier [16]. |
| Fmoc-Protected NNAAs | Building blocks for Solid-Phase Peptide Synthesis (SPPS) requiring orthogonal protection. | Provides backbone amine protection, removable with a base like piperidine [14]. |
| tBu-Protected NNAAs | Building blocks for SPPS requiring orthogonal protection. | Provides carboxylic acid protection, removable with strong acid like TFA [14]. |
| NNAA-Synth Software | Plans & evaluates synthesis routes for non-natural amino acids, including protection groups. | Integrates retrosynthetic prediction with deep learning-based feasibility scoring [14]. |
| SynFrag Platform | Predicts synthetic accessibility (SA) of molecules via fragment assembly generation. | Provides rapid, interpretable SA scores for high-throughput screening in drug discovery [10]. |
| CMD-GEN Framework | A structure-based deep generative model for designing active, drug-like molecules. | Uses coarse-grained pharmacophore points to bridge protein-ligand complexes with synthesizable molecules [15]. |
This diagram illustrates the core workflow for identifying active compounds through functional screening and validating them in vivo.
This diagram outlines the integrated computational and experimental pipeline for ensuring newly designed materials or drugs are synthesizable.
This technical support resource addresses common challenges in predicting material stability and synthesis feasibility, crucial for research in drug development and material science.
FAQ: How can I quickly predict if a newly designed material is thermodynamically stable? The formation energy of a compound is a primary indicator of its thermodynamic stability. A material is generally considered stable if its calculated formation energy lies on or below the convex hull of formation energies for all other possible phases of its constituent elements. A positive formation energy often indicates instability, while a negative value suggests a stable compound. Metastable materials, which can be synthesized under specific conditions, may have formation energies slightly above this hull [17].
Troubleshooting Guide: Discrepancies between predicted and experimental stability.
FAQ: Why is understanding the decomposition pathway important for material design? Identifying the specific chemical route a material takes when it breaks down allows researchers to design more robust compounds. By understanding the weak points in a molecular structure, chemists can strategically modify it to block or slow the primary decomposition mechanisms, thereby enhancing the material's operational lifetime and safety [18].
Troubleshooting Guide: Unexpected decomposition during application.
FAQ: How can I evaluate the synthesis feasibility of a novel non-natural amino acid (NAA) for peptide therapeutics?
Bridging in silico design to actual synthesis requires integrated tools that consider protection groups and reaction pathways. Tools like NNAA-Synth assist by [14]:
Troubleshooting Guide: Low yield during the synthesis of a protected building block.
The following parameters are critical for computational and experimental characterization of new materials.
Table 1: Key Physicochemical and Performance Parameters for Energetic Materials [19]
| Parameter | Description | Significance |
|---|---|---|
| Density | Mass per unit volume. | Directly influences detonation performance. |
| Heat of Formation | Energy change when a compound is formed from its elements. | A higher positive value contributes to greater energy content. |
| Detonation Velocity | Speed of the detonation wave through the material. | Key metric for explosive performance. |
| Detonation Pressure | Pressure at the front of the detonation wave. | Key metric for explosive performance and brisance. |
| Impact Sensitivity | Measure of the likelihood of initiation by impact. | Critical safety parameter (lower is safer). |
| Friction Sensitivity | Measure of the likelihood of initiation by friction. | Critical safety parameter (lower is safer). |
| Thermal Stability | The decomposition temperature of the material. | Indicates safe handling and storage temperature range. |
Table 2: Key Descriptors for Computational Workflows [20] [17]
| Descriptor | Description | Role in Feasibility |
|---|---|---|
| Formation Energy | Energy of a compound relative to its constituent elements. | Primary metric for thermodynamic stability. |
| Energy Above Hull | Energy relative to the most stable phase configuration. | Identifies stable and metastable compounds; a value of 0 indicates the most stable phase. |
| Space Group | Crystallographic classification defining symmetry. | Critical input feature for accurate formation energy prediction, accounting for polymorphs [17]. |
| Surface Structure Geometry | The shape and atomic arrangement of a crystal surface. | Determines the feasibility of forming intergrowth structures between different zeolites [20]. |
This methodology accelerates the initial screening of material stability [17].
1. Data Preprocessing
2. Deep Learning Architecture and Training
3. Model Evaluation
This protocol outlines steps to identify degradation mechanisms in functional molecules, such as battery anolytes [18].
1. Cycling and Sample Collection
2. Identification of Decomposition Products
3. Computational Analysis with Density Functional Theory (DFT)
4. Mitigation via Structural Design
Stability and Synthesis Workflow
Table 3: Key Reagents for Non-Natural Amino Acid Synthesis and Protection [14]
| Reagent / Protecting Group | Function / Role in Synthesis |
|---|---|
| Fmoc-Cl (Fluorenylmethyloxycarbonyl chloride) | Used to protect the backbone amino group (-NHâ). It is removable under basic conditions (e.g., piperidine), making it orthogonal to acid-labile groups. |
| tBu (tert-Butyl esters) | Used to protect the backbone carboxylic acid (-COOH). It is cleaved by strong acids like trifluoroacetic acid (TFA). |
| Bn (Benzyl) / 2ClZ (2-Chlorobenzyloxycarbonyl) | Used to protect sidechain acids, alcohols, or amines. These groups are removed by hydrogenolysis, providing orthogonality to both acid and base labile protections. |
| PMB (p-Methoxybenzyl) | Used to protect sidechain hydroxyls or thiols. It is cleaved oxidatively (e.g., with DDQ), offering another orthogonal deprotection strategy. |
| TMSE (Trimethylsilyl-ethyl) | Used to protect sidechain acids or alcohols. It is selectively removed with fluoride ions (e.g., TBAF), stable to other deprotection conditions. |
| NNAA-Synth Tool | A cheminformatics tool that integrates protection group assignment, retrosynthetic planning, and deep learning-based feasibility scoring to streamline the synthesis of protected NAAs [14]. |
| Epanolol-d5 | Epanolol-d5, MF:C20H23N3O4, MW:374.4 g/mol |
| Damnacanthal-d3 | Damnacanthal-d3, MF:C16H10O5, MW:285.26 g/mol |
The table below summarizes the primary methods used for the synthesis of inorganic materials, helping researchers select the appropriate technique based on their target material's requirements.
| Method Category | Specific Technique | Key Application Examples | Critical Parameters | Key Advantages | Primary Limitations |
|---|---|---|---|---|---|
| Solid-State & High-Temperature [21] | Traditional Solid-State Reaction | Ceramics, Metal oxides, Superconductors | Temperature (500-2000°C), Grinding cycles, Reactant surface area [21] | Simplicity, Yields thermodynamically stable products [21] | Slow diffusion, Potential for incomplete reactions, Irregular particle size/shape [21] [22] |
| Solid-State & High-Temperature [21] | Flux Method | Single crystals, Metastable phases | Molten salt/metal medium, Reaction temperature [21] | Lower reaction temperature, Improved diffusion [21] | Use of a flux medium required |
| Solid-State & High-Temperature [21] [2] | Chemical Vapour Deposition (CVD) | Semiconductor thin films, Optical coatings | Precursor gas composition, Substrate temperature, Chamber pressure [21] | High-purity, uniform coatings [21] | Complex equipment and gas handling |
| Solid-State & High-Temperature [2] | High-Pressure Synthesis | High-Tc superconductors, Super-hard nano-diamonds | Applied pressure, Temperature [2] | Access to unprecedented novel materials [2] | Requires specialized high-pressure equipment |
| Solution-Based [21] | Sol-Gel Method | Glasses, Ceramics, Hybrid materials | Precursor chemistry, pH, Temperature, Gelation time [21] | Low processing temperatures, Porous materials [21] | Potential for shrinkage during drying |
| Solution-Based [21] | Hydrothermal/Solvothermal | Zeolites, Quartz crystals, Nanomaterials | Solvent type, Temperature (>100°C), Pressure (autoclave) [21] | Forms materials difficult to synthesize by other methods [21] | Requires sealed pressure vessels |
| Solution-Based [21] | Precipitation | Nanoparticles, Phosphors, Catalysts | Concentration, Temperature, pH, Addition rate [21] | Good for nanoparticle synthesis | Control over particle size distribution can be challenging |
| Energy-Assisted [21] | Electrochemical Synthesis | Metals, Alloys, Conductive polymers | Electrode potential, Current density, Electrolyte [21] | Synthesizes materials difficult to produce by other methods [21] | Requires electrode setup and conductivity |
| Energy-Assisted [21] | Mechanochemical | Alloys, Composites, Nanomaterials | Milling type, Duration, Energy input [21] | Forms metastable phases, Nanostructured materials [21] | Potential for contamination from milling media |
| Energy-Assisted [21] [23] | Microwave-Assisted | Nanoparticles, MOFs, Hybrids | Microwave power, Solvent, Reaction time [21] | Rapid, uniform heating, Energy efficient [21] | Requires specialized microwave reactors |
| Energy-Assisted [23] | Gamma Irradiation | Metallic nanoparticles, Nanocomposites | Radiation dose, Radical scavengers (e.g., isopropanol) [23] | Room temperature/pressure, High purity, No reducing agents [23] | Potential for radioactivity if neutron exposure occurs [23] |
A: This is a common limitation due to slow solid-state diffusion [21]. To overcome this:
A: Synthesizing metastable phases requires bypassing the most stable free energy minimum. Conventional solid-state reactions typically yield the most stable phase [22]. Recommended approaches are:
A: In fluid-phase synthesis, the separation of nucleation and growth stages is key to achieving monodisperse particles [22].
A: Radioactivity is caused by neutron absorption reactions, not gamma rays themselves [23].
Principle: Direct reaction between solid precursors at high temperatures to form a new crystalline phase [21].
Step-by-Step Procedure:
Troubleshooting Tip: If reaction completion is slow, consider using a mineralizer (e.g., a small amount of volatile halide) or increase the number of grinding and heating cycles [21].
Principle: Formation of an inorganic network through the hydrolysis and condensation of molecular precursors in a liquid medium [21].
Step-by-Step Procedure:
Troubleshooting Tip: Rapid hydrolysis can lead to precipitation instead of gelation. Control the rate of water addition and the strength of the catalyst to manage the process [21].
The table below lists essential reagents and materials frequently used in inorganic synthesis, along with their core functions.
| Reagent/Material | Function in Synthesis |
|---|---|
| Metal Oxides/Carbonates | Common solid-state precursors for ceramics and mixed metal oxides [21]. |
| Metal Alkoxides | Common molecular precursors for sol-gel synthesis (e.g., TEOS for SiO2) [21]. |
| Flux Agents (e.g., NaCl, PbO) | Molten media in flux methods to enhance diffusion and crystal growth at lower temperatures [21]. |
| Structure-Directing Agents (e.g., Quaternary Ammonium Salts) | Templates for creating porous materials like zeolites during hydrothermal synthesis [21]. |
| Surfactants & Capping Agents (e.g., CTAB, PVP) | Control nucleation, growth, and agglomeration during nanoparticle synthesis in solution [21]. |
| Reducing Agents (e.g., NaBH4) | Chemically reduce metal ions to form metallic nanoparticles in precipitation methods. Note: Not required in gamma irradiation [23]. |
| Radical Scavengers (e.g., Isopropanol) | Scavenge OH⢠and H⢠radicals in gamma irradiation synthesis to control reduction reactions and prevent unwanted side products [23]. |
| Boc-amino-PEG3-SSPy | Boc-amino-PEG3-SSPy, MF:C18H30N2O5S2, MW:418.6 g/mol |
| 8H-Furo[3,2-g]indole | 8H-Furo[3,2-g]indole, CAS:863994-90-5, MF:C10H7NO, MW:157.17 g/mol |
The diagram below outlines a logical workflow for identifying materials with high synthesis feasibility, integrating traditional and modern data-driven approaches.
Q1: What are the primary advantages of using HPHT synthesis in materials research?
HPHT synthesis is a powerful method for creating materials with unique properties that are not achievable under ambient conditions. The application of high pressure effectively decreases atomic volume and increases the electronic density of reactants, which can lead to the formation of new chemical bonds and structural transformations [24]. This technique is crucial for producing superhard materials like diamond and cubic boron nitride, discovering new superconducting materials with enhanced critical temperatures, and synthesizing nanomaterials with exotic phases [25] [24] [26]. For instance, high pressure has been used to stabilize high-temperature superconducting phases in iron-based superconductors and to enhance the critical current density in materials like MgBâ [24] [26].
Q2: What are the main types of high-pressure apparatus available, and how do I choose?
The choice of apparatus depends on your target pressure, sample volume, and required sample quality. The main technologies are compared below [25] [24] [26]:
| Apparatus Type | Typical Pressure Range | Sample Volume | Key Characteristics |
|---|---|---|---|
| Piston-Cylinder | Up to 3 GPa | 1 - 1000 cm³ | Large sample volume; suitable for a wide range of syntheses [24]. |
| Bridgman Anvil | 15 - 300 GPa | Very small | Very high pressures; hard alloy (15-20 GPa), SiC (20-70 GPa), or diamond anvils (100-300 GPa) [24]. |
| Multi-Anvil Press (e.g., Walker-type) | Over 5 GPa | ~1 cm³ | Industrially scalable for superhard materials; used for catalyst-free diamond synthesis [27] [24]. |
| Gas Pressure Technique (HP-HTS) | Up to 3 GPa | 10 - 15 cm³ | Large, high-quality samples; homogeneous temperature/pressure; avoids contamination [26]. |
| Shock Wave (Dynamic) | 10 - 1000 GPa | 1 - 10 cm³ | Very high pressures for short durations (nanoseconds) [24]. |
Q3: My HPHT synthesis yielded a product with unintended phases or poor purity. What could be the cause?
Contamination is a common issue. In solid-medium pressure systems, physical interactions between the sample and the instrument parts (e.g., anvils, pressure-transmitting medium) can introduce impurities that compromise the final product [26]. Another cause could be the evaporation of lighter elements from the sample, which can be controlled by using a high-gas pressure technique that creates a confined environment [26]. Furthermore, if the pressure and temperature distribution within the reaction chamber is not homogeneous, it can lead to undefined preparation conditions and inconsistent results. The high-gas pressure technique is noted for its ability to provide homogeneous conditions [26].
Q4: During my experiment, I cannot reach the target pressure. What should I check?
This problem can originate from several parts of the system. You should investigate the following [28]:
Q5: How can I safely cool down my system and handle the synthesized material after an HPHT experiment?
Improper cooling can cause thermal shock, leading to cracks in the synthesized material or damage to the equipment. It is crucial to follow a controlled cooling rate as specified for your apparatus and material [28]. If the cooling system itself fails, it can cause dangerously high temperatures; always check that the coolant flow is sufficient and the system is free of blockages [28]. After the run, be aware that some synthesized phases are metastable and may not be retained upon decompression to ambient pressure. Ensure you understand the phase stability of your target material [24].
Gas leakage compromises pressure build-up and can contaminate the sample.
| Symptom | Possible Cause | Solution |
|---|---|---|
| Gas pressure cannot reach the expected value. | Damaged or improperly installed sealing gasket. | Inspect seals regularly; replace if aged or damaged; ensure proper installation per manufacturer's instructions [28]. |
| Leaking threaded connections. | Ensure all threaded connections are tight; apply a suitable sealant; replace damaged threaded parts [28]. |
Failure to achieve or maintain target conditions directly impacts reaction outcomes.
| Symptom | Possible Cause | Solution |
|---|---|---|
| Pressure sensor readings are inaccurate or control system fails. | Sensor or control system failure. | Check and calibrate pressure sensors; inspect control system circuits and software; contact technical support if needed [28]. |
| Temperature cannot reach the set value. | Heating system failure. | Check and repair heating elements; verify and adjust heating rate and temperature settings [28]. |
| Unintended pressure drop during reaction. | Leakage (see above) or material clogging. | Check for leaks. Also, inspect valves and pipelines for blockages from solid materials or high-viscosity liquids; clean regularly [28]. |
Common problems related to the final synthesized material.
| Symptom | Possible Cause | Solution |
|---|---|---|
| Unintended phases or impurities in the final product. | Contamination from the pressure medium or sample evaporation. | Use a high-gas pressure technique to avoid contact with solid media and control evaporation of light elements [26]. |
| Metallic inclusions in synthesized diamonds. | Use of metal catalyst (Fe, Ni, Co) in HPHT growth. | To avoid inclusions that compromise optical/electrical properties, use a catalyst-free HPHT process at higher pressures (e.g., 15 GPa) [27] [29]. |
| Poor densification or sintering of the product. | Insufficient pressure and temperature for mass transport. | Increase pressure to enhance densification rate, as pressure reduces diffusion distances between particles [24]. |
This protocol outlines the direct conversion of BaCOâ to micron-sized diamond using a hexahedral multi-anvil press, a method relevant for utilizing radioactive carbon-14 from nuclear waste [27].
1. Principle: The process subjects BaCOâ precursor powder to extreme conditions of 15 GPa and 2300 K (â2027°C). Under these conditions, the carbonate decomposes, and carbon rearranges into the diamond lattice without the use of metal catalysts, preventing metallic contamination [27].
2. Equipment and Reagents:
3. Step-by-Step Procedure:
4. Characterization:
This protocol uses a high-purity gas pressure system, ideal for growing large, high-quality crystals of complex materials like iron-based superconductors (FBS) with minimal contamination [26].
1. Principle: An inert gas (e.g., argon) is compressed to gigapascal-level pressures using a multi-stage piston compressor. This high-pressure gas environment suppresses the evaporation of volatile elements and allows for homogeneous crystal growth at high temperatures within a large sample volume [26].
2. Equipment and Reagents:
3. Step-by-Step Procedure:
4. Characterization: Enhanced superconducting properties are typically confirmed by measuring:
| Item | Function & Application |
|---|---|
| Metal Catalysts (Fe, Ni, Co) | Solvents/catalysts in traditional HPHT diamond growth; lower the required temperature and pressure for graphite-to-diamond conversion [29]. |
| High-Purity Carbon Sources (Graphite, BaCOâ) | Carbon precursors. Graphite is common, while BaCOâ is used for specific pathways, such as direct conversion for diamond battery technology [27] [29]. |
| Boron Dopant | Added during HPHT diamond growth to create p-type semiconducting blue diamonds [29]. |
| Pressure Transmitting Media (e.g., Octahedral MgO) | Encapsulates the sample in multi-anvil presses to ensure hydrostatic (uniform) pressure distribution during synthesis [27]. |
| Sealing Gaskets | Critical components in autoclaves and pressure chambers to maintain a gas-tight seal and prevent leaks under extreme conditions [28]. |
| Hydrocarbon Gas (e.g., Methane) | Serves as the carbon source in Chemical Vapor Deposition (CVD) diamond growth, where it decomposes in a plasma to deposit carbon on a substrate [29]. |
| 1-Dodecene, 12-iodo- | 1-Dodecene, 12-iodo-, CAS:144633-22-7, MF:C12H23I, MW:294.22 g/mol |
| Ethyl docos-2-enoate | Ethyl docos-2-enoate|Alpha,Beta-Unsaturated Ester |
HPHT Synthesis General Workflow
High Gas Pressure System Diagram
| Question | Answer |
|---|---|
| What is the primary advantage of hydrothermal synthesis? | It is a cost-effective and scalable solution-based method allowing precise control over morphology and phase purity of nanomaterials at relatively low temperatures [30]. |
| Why is controlled nucleation critical? | Uncontrolled, stochastic nucleation leads to heterogeneous product quality, inconsistent drying rates, and can compromise the yield and activity of sensitive biologics [31]. |
| My VS2 nanosheets are impure. What should I check? | Systematically optimize precursor molar ratio (NH4VO3:TAA), reaction temperature, and ammonia concentration. Pure phase VS2 can be achieved in 5 hours with correct parameters [30]. |
| How can I improve the monodispersity of my spherical Al2O3 powder? | Control the hydrothermal reaction temperature and precursor concentration to direct the nucleation and growth of uniform spherical precursors before calcination [32]. |
| What is an inert alternative to metal reactors for hydrothermal experiments? | Quartz or fused silica glass tubes are cost-effective and highly inert, minimizing unwanted catalytic effects in organic-mineral hydrothermal interactions [33]. |
Issue: The final product has inconsistent shape, size, or contains undesired crystalline phases.
| Potential Cause | Solution | Supporting Data / Protocol Step |
|---|---|---|
| Unoptimized precursor ratio and concentration | Systematically vary molar ratios. For VS2, test NH4VO3:TAA ratios of 1:2.5, 1:5, 1:7.5, and 3:5 [30]. | Precursor concentration should be controlled; for spherical Al2O3, Al³⺠concentration was precisely maintained at 0.02 mol/L [32]. |
| Incorrect reaction temperature | Optimize temperature profile. VS2 growth was studied at 100°C, 140°C, 180°C, and 220°C [30]. | Phase transformation in Al2O3 during calcination is temperature-dependent; α-Al2O3 forms efficiently at high temperatures [32]. |
| Uncontrolled nucleation | Implement methods to control the nucleation event. For lyophilization, pressure manipulation can induce uniform nucleation; similar principles can apply to hydrothermal systems [31]. | Uncontrolled nucleation causes vial-to-vial heterogeneity in freezing and drying characteristics, directly impacting final product attributes [31]. |
Issue: The amount of final product is lower than expected, or recovery from the solution is inefficient.
| Potential Cause | Solution | Supporting Data / Protocol Step |
|---|---|---|
| Insufficient or excessive reaction time | Determine the minimum time for phase purity. VS2 nanosheets can be synthesized in 5 hours, much less than the conventional 20 hours [30]. | For organic-mineral experiments, a 2-hour reaction at 150°C was sufficient to show significant mineral-catalyzed conversion [33]. |
| Inefficient product extraction | Ensure thorough washing and extraction steps. Use multiple solvents and sonication for better recovery [33]. | After hydrothermal reaction, products were extracted with dichloromethane, vortexed for 1 min, and sonicated for samples with high mineral content [33]. |
| Precursor reactivity and stability | Design molecular precursors with controlled reactivity. For HfBCN ceramics, modifying the molecular structure stabilized the metal center and improved processability [34]. | The designed Hf-N-B molecular framework reduced the reactivity of the hafnium central atom, leading to a better ceramic yield of 53.07 wt% [34]. |
This protocol is adapted for studying organic-mineral interactions under hydrothermal conditions using inert silica tubes [33].
1. Sample Preparation
2. Hydrothermal Experiment Setup
3. Post-Reaction Analysis
The table below summarizes critical parameters for the controlled hydrothermal growth of VS2 nanosheets.
| Parameter | Values Tested | Optimal / Notable Condition |
|---|---|---|
| Precursor Molar Ratio (NH4VO3:TAA) | 1:2.5, 1:5, 1:7.5, 3:5 | Systematically optimized for phase purity. |
| Reaction Temperature | 100°C, 140°C, 180°C, 220°C | Significantly affects nucleation and growth rate. |
| Reaction Time | â¤1, 2, 3, 5, 10, 20 hours | Pure VS2 achieved in just 5 hours. |
| Ammonia Concentration | 2 mL, 4 mL, 6 mL | Affects solubility and reaction pathway. |
Understanding the temperature-dependent phase transformation is crucial for achieving the desired final material.
| Calcination Step | Phase Transformation | Key Finding |
|---|---|---|
| Heat Treatment | Amorphous Al(OH)â â Amorphous AlâOâ â γ-AlâOâ â α-AlâOâ | The sequence is critical for obtaining the stable α-phase. |
| Crystallization | Transition to γ-AlâOâ occurs at ~400°C. | |
| Phase Stabilization | Transition to α-AlâOâ occurs at ~1200°C. |
| Reagent / Material | Function in Hydrothermal Synthesis |
|---|---|
| Quartz or Silica Glass Tubes | Inert reaction vessel to minimize catalytic interference during organic-mineral hydrothermal studies [33]. |
| Ammonia Solution (NHâ·HâO) | A mineralizer that increases the solubility of precursor materials, influencing reaction kinetics and product morphology [30]. |
| Thioacetamide (TAA) | A common sulfur precursor for the hydrothermal synthesis of sulfide materials like VS2 [30]. |
| Urea | Acts as a precipitating agent in the hydrothermal synthesis of spherical oxide precursors (e.g., AlâOâ) [32]. |
| Polyethylene Glycol (PEG) | A dispersant used to prevent agglomeration of precursor particles, promoting a uniform particle size distribution [32]. |
| 4-Ethynylpyrene | 4-Ethynylpyrene|Research Chemical |
| Undec-1-EN-9-yne | Undec-1-EN-9-yne|High-Purity Research Chemical |
Problem: Endotoxin and Microbial Contamination
Problem: Poor Control Over Nanoparticle Size and Shape
Problem: Low Yield and Scalability Issues
Problem: Nanoparticle Aggregation and Instability
Problem: Interference with Characterization Techniques
Table 1: Analytical Techniques for Biogenic Nanoparticle Characterization
| Technique | Parameters Measured | Common Pitfalls | Solutions |
|---|---|---|---|
| Dynamic Light Scattering (DLS) | Hydrodynamic size, size distribution | Overestimation of size due to aggregation; interference from biological matrix | Combine with electron microscopy; filter samples properly before analysis |
| UV-Vis Spectroscopy | Surface plasmon resonance, concentration | Broad peaks indicating polydispersity; scattering effects from large particles | Use appropriate baseline corrections; monitor peak symmetry and width |
| Transmission Electron Microscopy (TEM) | Core size, shape, morphology | Sample preparation artifacts; poor statistical representation | Analyze multiple fields; ensure proper staining and grid preparation |
| Zeta Potential | Surface charge, stability | Influence of biological corona; sensitivity to pH and ionic strength | Measure under physiological conditions; report multiple measurement conditions |
| FTIR Spectroscopy | Surface functional groups, capping agents | Signal overlap from complex biological matrices | Use complementary techniques like NMR or XPS for validation |
Q: What are the main advantages of green synthesis over chemical methods for nanoparticle production?
A: Green synthesis offers several key advantages: (1) It eliminates or reduces the use of hazardous chemicals, making it more environmentally friendly [41] [39]; (2) It utilizes biological reducing and stabilizing agents that are renewable, biodegradable, and often less expensive than chemical alternatives [40] [39]; (3) The resulting nanoparticles often exhibit inherent biocompatibility due to their biological coatings, making them particularly suitable for biomedical applications [38] [39]; (4) It typically operates under ambient temperature and pressure conditions, reducing energy consumption [39].
Q: How can I improve reproducibility in biogenic nanoparticle synthesis?
A: Improving reproducibility requires: (1) Standardizing biological sources by controlling growth conditions, harvest timing, and extraction methods for consistent metabolite profiles [36] [38]; (2) Documenting all reagent lots and sources, as natural variations can significantly impact results [37]; (3) Maintaining precise control over reaction parameters (pH, temperature, incubation time) and using mass measurements for critical reagents [38] [37]; (4) Implementing rigorous characterization protocols for both starting materials and final products [35] [36]; (5) Conducting regular small-scale pilot studies to monitor process consistency [37].
Q: What are the key factors that influence the size and shape of biogenically synthesized nanoparticles?
A: The main factors include: (1) Type and concentration of biological reducing agents (enzymes, phytochemicals) in the extract [38] [39]; (2) Reaction conditions such as pH, temperature, and incubation time [38]; (3) Precursor ion concentration and the ratio of precursor to reducing agents [38] [37]; (4) Incubation time - longer reactions often yield larger particles [38]; (5) Specific biomolecules present that act as capping or shape-directing agents [36] [38].
Q: How can I control the aspect ratio of anisotropic nanoparticles like gold nanorods?
A: Controlling aspect ratio requires careful manipulation of synthesis conditions: (1) For gold nanorods, silver nitrate concentration is a key parameter - increasing concentration generally increases aspect ratio up to ~850 nm LSPR [37]; (2) Using binary surfactant systems (e.g., CTAB with BDAC or sodium oleate) enables higher aspect ratios (up to 10) [37]; (3) Implementing multistage addition of growth solution to seeds can achieve extremely high aspect ratios (up to 70) [37]; (4) The amount of seed particles used inversely affects aspect ratio - more seeds typically yield shorter nanorods [37].
Q: What are the main challenges in scaling up biogenic nanoparticle production?
A: Scale-up challenges include: (1) Batch-to-batch variability due to biological heterogeneity [36] [38]; (2) Difficulty in maintaining precise control over reaction parameters in large volumes [36]; (3) Downstream purification complexities, particularly for intracellularly synthesized nanoparticles [36] [38]; (4) Cost-effective sourcing of biological materials in large quantities [40] [42]; (5) Ensuring consistent nanoparticle properties (size, shape, surface chemistry) across production scales [36] [38].
Table 2: Optimization of Reaction Conditions for Biogenic Synthesis
| Parameter | Effect on Nanoparticle Properties | Optimal Range/Approach |
|---|---|---|
| pH | Affects reduction rate and mechanism; influences nanoparticle size and shape | Varies by biological system; typically slightly acidic to neutral (pH 5-7) for most metallic nanoparticles |
| Temperature | Higher temperatures generally accelerate reduction rates and affect size | Room temperature to mild heating (25-80°C); varies by biological system tolerance |
| Incubation Time | Longer times typically yield larger particles; affects crystallinity | Several minutes to hours; must be optimized for each system |
| Precursor Concentration | Higher concentrations can increase yield but may cause aggregation | Typically 0.1-10 mM; must be balanced with reducing capacity of biological source |
| Biological Extract Concentration | Affects reduction rate and capping efficiency; influences size distribution | Varies by source; requires empirical optimization for each system |
Materials Required:
Procedure:
Metal Salt Solution Preparation: Prepare fresh aqueous solution of metal salt (concentration typically 0.1-10 mM) using deionized, ultrafiltrated water (18.2 MΩ·cm ASTM Type I) [37].
Reaction Setup: Combine plant extract and metal salt solution in appropriate ratio (typically 1:9 to 1:1 v/v) under continuous stirring (200-500 rpm). Maintain constant temperature (typically 25-80°C depending on system). Monitor color change indicating nanoparticle formation [39].
Purification: Separate nanoparticles by centrifugation (typically 10,000-50,000 Ã g for 10-30 minutes). Wash pellet multiple times with sterile water or appropriate buffer to remove unreacted components. Resuspend in desired storage medium [39].
Characterization: Analyze using UV-Vis spectroscopy, DLS, TEM/SEM, zeta potential, and FTIR as described in characterization section [39].
Materials Required:
Procedure:
Exposure to Metal Precursor: Add filter-sterilized metal salt solution to culture (concentration typically 0.1-5 mM). For extracellular synthesis, use culture supernatant or cell-free filtrate. For intracellular synthesis, use live cells [38].
Incubation: Incubate under optimal growth conditions with shaking (if aerobic) for specified time (typically 1-72 hours). Monitor nanoparticle formation by color change or UV-Vis spectroscopy [38].
Harvesting: For extracellular synthesis, separate cells by centrifugation and collect supernatant containing nanoparticles. For intracellular synthesis, harvest cells by centrifugation, wash, and disrupt using sonication or enzymatic lysis to release nanoparticles [38].
Purification and Characterization: Purify nanoparticles using centrifugation, filtration, or chromatography. Characterize as described previously [38].
Table 3: Essential Reagents for Green Nanoparticle Synthesis
| Reagent Category | Specific Examples | Function | Critical Quality Controls |
|---|---|---|---|
| Biological Sources | Plant extracts (Neem, Aloe vera, Green tea); Microorganisms (E. coli, Fusarium oxysporum, Spirulina platensis) | Provide reducing and stabilizing agents (enzymes, phytochemicals, metabolites) | Standardize extraction protocol; verify species identity; control growth conditions; document geographical and seasonal variations |
| Metal Precursors | Silver nitrate (AgNOâ), Chloroauric acid (HAuClâ), Zinc acetate, Selenium salts | Source of metal ions for nanoparticle formation | Use high-purity grades; prepare fresh solutions; protect from light; track lot-to-lot variability |
| Surfactants/Stabilizers | CTAB, Sodium oleate, BDAC, Chitosan, Plant polysaccharides | Control nanoparticle growth and prevent aggregation | Verify purity; monitor age of solutions; test for endotoxin contamination |
| Solvents and Buffers | Deionized ultrafiltrated water (18.2 MΩ·cm), Ethanol, Phosphate buffers | Reaction medium and purification | Use LAL-grade/pyrogen-free water for biological applications; ensure sterility; control pH precisely |
| Purification Aids | Cellulose membranes, Centrifugal filters, Chromatography resins | Separate nanoparticles from reaction mixture | Select appropriate pore sizes; pre-clean to remove contaminants; avoid cellulose-based filters for endotoxin-sensitive applications |
This support center addresses common technical issues encountered when implementing machine learning (ML) for predictive synthesis and feasibility screening in materials and drug discovery. The guidance is based on established experimental protocols and diagnostic accuracy studies.
Q1: Our ML model for predicting reaction feasibility achieves high accuracy on training data but performs poorly on new, unseen substrate combinations. What could be the cause and how can we resolve this?
A: This is a classic case of model overfitting [43]. The model has learned the noise and specific patterns of your training data instead of the underlying generalizable rules.
Q2: When using an automated tool for literature screening of randomized controlled trials (RCTs), we are concerned about missing relevant studies (false negatives). Which tools are most reliable and how can we configure them for minimal oversight?
A: Diagnostic accuracy studies have evaluated this specific concern. The key is to select a tool with a low False Negative Fraction (FNF).
Q3: Our high-throughput experimentation (HTE) platform generates vast amounts of data, but we struggle with predicting reaction robustness and reproducibility for industrial scale-up. How can ML help?
A: Robustnessâhow a reaction withstands minor environmental changesâis a major challenge. Bayesian Deep Learning is specifically suited for this.
Q4: The chemical space for our target materials is enormous. How can we efficiently explore it with ML without running an infeasible number of experiments?
A: An active learning strategy guided by model uncertainty can dramatically reduce data requirements.
The following table summarizes the diagnostic performance of various AI tools for literature screening, specifically for identifying Randomized Controlled Trials (RCTs). A lower False Negative Fraction (FNF) is critical to avoid missing relevant studies [45].
Table 1: Performance Metrics of AI Tools for RCT Screening
| AI Tool | False Negative Fraction (FNF) for RCTs | False Positive Fraction (FPF) for Non-RCTs | Mean Screening Time per Article (seconds) |
|---|---|---|---|
| RobotSearch | 6.4% (95% CI: 4.6% to 8.9%) | 22.2% (95% CI: 18.8% to 26.1%) | Data Not Available |
| ChatGPT 4.0 | 7.2% (95% CI: 5.2% to 9.9%) | 3.8% (95% CI: 2.4% to 5.9%) | 1.3 |
| Claude 3.5 | 9.2% (95% CI: 7.0% to 12.1%) | 2.8% (95% CI: 1.7% to 4.7%) | 6.0 |
| Gemini 1.5 | 13.0% (95% CI: 10.3% to 16.3%) | 3.4% (95% CI: 2.1% to 5.4%) | 1.2 |
| DeepSeek-V3 | 8.8% (95% CI: 6.6% to 11.7%) | 3.2% (95% CI: 2.0% to 5.1%) | 2.6 |
This protocol outlines the integrated HTE and Bayesian ML workflow for global reaction feasibility and robustness prediction, as validated in recent research [44].
1. Objective: To predict the feasibility and intrinsic robustness of acid-amine coupling reactions across a broad, industrially relevant chemical space with minimal data requirements.
2. Materials & Workflow:
3. Key Procedures:
Diversity-Guided Substrate Down-Sampling:
Automated High-Throughput Experimentation:
Bayesian Neural Network (BNN) Training & Active Learning:
Robustness Assessment via Uncertainty Disentanglement:
Table 2: Essential Components for an ML-Driven Feasibility Screening Workflow
| Tool / Reagent | Function & Rationale |
|---|---|
| Automated HTE Platform | A robotic system (e.g., CASL-V1.1) that enables the rapid, parallel execution of thousands of micro-scale reactions. It is fundamental for generating the large, consistent datasets required for ML [44]. |
| Bayesian Neural Network (BNN) | The core ML model. It provides not just a prediction (e.g., feasible/not feasible) but also a reliable measure of its own uncertainty, which is essential for active learning and robustness assessment [44]. |
| Liquid Chromatography-Mass Spectrometry (LC-MS) | The analytical workhorse for HTE. It provides uncalibrated yield measurements for a high volume of reactions quickly, forming the primary data labels for model training [44]. |
| Diversity-Based Sampling Script | A computational script (e.g., using MaxMin algorithm) to select a representative subset of substrates from a vast commercial library, ensuring efficient exploration of the chemical space [44]. |
| Condensation Reagents & Bases | A curated set of common reagents (e.g., 6 condensation reagents, 2 bases) used to explore the condition space alongside the substrate space, providing a more complete picture of reaction feasibility [44]. |
| C24H25ClFN3O2 | Adoprazine Hydrochloride (C24H25ClFN3O2) |
| 4-Fluoro-4H-pyrazole | 4-Fluoro-4H-pyrazole, CAS:921604-88-8, MF:C3H3FN2, MW:86.07 g/mol |
This technical support center provides troubleshooting guides and FAQs for researchers developing materials with high synthesis feasibility. The content focuses on resolving common experimental challenges in accelerated discovery workflows, particularly those integrating AI, automation, and advanced characterization.
Q: Our AI models for material discovery show high predictive accuracy in validation, but consistently propose synthetic pathways with impractical precursor requirements or extreme conditions. What steps can we take to improve real-world feasibility?
A: This common issue, the "reality gap," often arises from training data bias. Implement these corrective measures:
Q: During the development of radiopharmaceutical conjugates or new solid-state materials, we encounter high batch-to-batch variability in key quality attributes (e.g., particle size, ligand density). Our current quality control process is slow and creates a bottleneck. How can we ensure consistency without sacrificing speed?
A: Variability is a major risk for certification. Deployment of rapid, non-destructive analytical tools is key.
Q: When using high-throughput automation to explore new chemical spaces (e.g., for high-entropy alloys or PROTAC drugs), the volume of generated data is overwhelming. Our current data management practices are inconsistent, making replication and analysis difficult. What is the best practice for data handling?
A: Inconsistent data is a primary barrier to certification in regulated industries. A robust data strategy is non-negotiable.
Problem: Inconsistent Yield in Automated High-Throughput Synthesis of Metal-Organic Frameworks (MOFs) MOFs are target materials for defense applications in sensing and protection. Inconsistent yield in an automated platform halts discovery.
Problem: AI for Material Design Fails to Propose Novel, High-Performing Candidates The AI model for discovering new super-hard materials or organic semiconductors gets stuck in a local minima of the design space and only suggests minor variations of known compounds.
Protocol 1: Non-Destructive Quantification of Critical Quality Attributes (CQAs) in Powdered Materials Using Miniature NIR Spectroscopy and a Transformer Model
This protocol is essential for rapid, non-destructive quality control of synthesized materials, such as active pharmaceutical ingredients (APIs) or energetic materials, accelerating their certification.
Protocol 2: Active Learning Cycle for Closed-Loop Optimization in a Self-Driving Lab (SDL)
This protocol outlines the core workflow for accelerating the discovery of materials with targeted properties, such as high-strength alloys or efficient battery electrolytes.
Table: Essential Research Reagents and Materials
| Item | Function in Research | Example Application in Discovery |
|---|---|---|
| PROTAC Molecules [51] | Induce targeted degradation of specific proteins by recruiting E3 ubiquitin ligases. | Drug discovery for cancers, neurodegenerative diseases; targeting previously "undruggable" proteins. |
| Radiopharmaceutical Conjugates [51] | Combine a targeting molecule with a radioactive isotope for imaging (diagnostics) or therapy (theranostics). | Precision oncology; delivering lethal radiation directly to cancer cells while sparing healthy tissue. |
| Allogeneic CAR-T Cells [51] | "Off-the-shelf" engineered immune cells for cancer immunotherapy, derived from donors. | Scaling up CAR-T therapy for solid tumors; reducing cost and production time compared to autologous cells. |
| E3 Ubiquitin Ligases (e.g., Cereblon, VHL) [51] | Key cellular machinery utilized by PROTACs to label target proteins for degradation. | Expanding the toolbox for targeted protein degradation beyond the four most commonly used ligases. |
| CRISPR/Cas9 Systems [51] | Enable precise gene editing for functional genomics and therapeutic development. | Creating personalized gene therapies; rapid-response development for rare genetic diseases. |
SDL Closed-Loop Workflow
PROTAC Mechanism Pathway
Problem: My model for predicting novel 2D materials is failing to generalize. I have a very small amount of training data.
Explanation: Data scarcity is a primary challenge in machine learning, especially in specialized fields like materials science where data acquisition can be costly and time-consuming. A model trained on insufficient data cannot learn the underlying patterns effectively, leading to poor performance on new, unseen data [52] [53].
Solution:
Verification: After applying these techniques, compare the model's performance on a held-out test set using metrics appropriate for your task (e.g., F1-score, precision, recall). The performance should show significant improvement over a model trained from scratch only on your small dataset.
Problem: My classification model for identifying promising material synthesis pathways is highly accurate but ignores rare, promising candidates (the minority class).
Explanation: This is a classic problem of class imbalance. When one class (e.g., "non-feasible synthesis") significantly outnumbers another (e.g., "highly feasible synthesis"), the model becomes biased towards predicting the majority class, as this strategy alone can yield high accuracy. This makes the model useless for identifying the rare cases you are most interested in [54] [55] [56].
Solution:
BalancedBaggingClassifier internally balance the training set for each model in the ensemble, forcing the overall model to pay more attention to the minority class [56].Verification: Do not rely on accuracy. Use metrics like Precision, Recall, and the F1-score for the minority class to evaluate the model's effectiveness. A successful solution will show a marked increase in the Recall and F1-score for the minority class without a catastrophic drop in the performance for the majority class [56] [57].
Problem: The data I've extracted from material science literature is noisy, has inconsistent formats, and its annotation is a bottleneck.
Explanation: The "garbage in, garbage out" principle is fundamental in machine learning. Noisy, inconsistent, or poorly annotated data will prevent any model from learning correctly. In research fields, annotation often requires expert knowledge, making it a slow and expensive process [58] [53].
Solution:
Verification: Conduct thorough exploratory data analysis (EDA) before and after preprocessing to visualize the improvement in data quality. Monitor the model's training loss and performance metrics to ensure they are stable and improving, which indicates it is learning from clean signals.
Q1: What is the fundamental difference between data scarcity and class imbalance?
A1: Data scarcity refers to an overall insufficient volume of training data for a machine learning task. Class imbalance, on the other hand, describes a situation where the total amount of data might be sufficient, but the distribution across classes is skewed, with one class (the majority) having many more examples than another (the minority) [52] [54].
Q2: Why is accuracy a misleading metric for imbalanced classification problems?
A2: In a severely imbalanced dataset (e.g., 98% Class A, 2% Class B), a model that simply predicts the majority class (Class A) for every input will achieve 98% accuracy. This metric hides the fact that the model has completely failed to learn anything about the minority class (Class B), which is often the class of real interest [56] [57].
Q3: What are the potential downsides of basic oversampling and undersampling?
A3:
Q4: How can I access large-scale, curated data for materials science research?
A4: The research community is building public datasets to address this. One prominent example is the MatSyn25 dataset, a large-scale, open dataset containing over 163,000 entries on 2D material synthesis processes extracted from high-quality research articles [46]. Using such community resources can significantly mitigate data scarcity.
This table summarizes the core characteristics of different methods to handle class imbalance [54] [55] [56].
| Technique | Description | Key Advantages | Key Disadvantages | Typical Use Case |
|---|---|---|---|---|
| Random Oversampling | Randomly duplicates examples from the minority class. | Simple to implement; prevents model from ignoring minority class. | High risk of overfitting as model sees exact duplicates. | Mild imbalance; fast prototyping. |
| SMOTE | Creates synthetic minority class examples by interpolating between existing ones. | Reduces overfitting compared to random oversampling; introduces variety. | Can generate noisy samples if the minority class is not dense. | Moderate to severe imbalance where more diverse examples are needed. |
| Random Undersampling | Randomly removes examples from the majority class. | Reduces training time; helps model focus on learning decision boundaries. | Loss of potentially useful data from the majority class. | Very large datasets where majority class data is abundant. |
| Combined Sampling | Applies both oversampling (e.g., SMOTE) and undersampling. | Balances the benefits and drawbacks of both individual methods. | More complex to implement and tune. | Complex datasets where both information loss and overfitting are concerns. |
This table outlines appropriate metrics to replace accuracy when evaluating models on imbalanced datasets [56] [57].
| Metric | Formula (Simplified) | Focus | Interpretation |
|---|---|---|---|
| Precision | True Positives / (True Positives + False Positives) | The accuracy of positive predictions. | "When the model predicts the minority class, how often is it correct?" |
| Recall (Sensitivity) | True Positives / (True Positives + False Negatives) | The ability to find all positive instances. | "Of all the actual minority class samples, how many did the model find?" |
| F1-Score | 2 * (Precision * Recall) / (Precision + Recall) | The harmonic mean of Precision and Recall. | A single balanced metric that is high only if both Precision and Recall are high. |
| Specificity | True Negatives / (True Negatives + False Positives) | The ability to find all negative instances. | "Of all the actual majority class samples, how many did the model correctly reject?" |
The diagram below visualizes a recommended workflow for tackling these issues in a materials science research context.
This table details key computational "reagents" â algorithms and techniques â essential for building robust ML models in materials science under data constraints.
| Tool / Technique | Function in the Research Process | Relevant Context |
|---|---|---|
| Transfer Learning (TL) | Leverages knowledge from pre-trained models on large datasets (e.g., ImageNet, MatSyn25) to bootstrap learning on a smaller, specific materials dataset. | Addressing data scarcity [52] [53]. |
| SMOTE | Generates synthetic, plausible examples of the minority class (e.g., rare, feasible materials) to rebalance the training dataset and prevent model bias. | Addressing class imbalance [56]. |
| Active Learning | An iterative protocol that intelligently selects the most valuable data points for expert labeling, maximizing model performance while minimizing annotation cost. | Optimizing expert time and managing annotation scarcity [53]. |
| Physics-Informed NN (PINN) | Integrates known physical laws or domain knowledge (e.g., thermodynamic rules) directly as constraints in the model, reducing dependency on purely data-driven patterns. | Guiding models when data is scarce or noisy [52]. |
| BalancedBaggingClassifier | An ensemble method that ensures each model in the committee is trained on a balanced subset of data, making the overall system more attentive to minority classes. | Handling class imbalance without manual resampling [56]. |
| C12H18N2OS3 | C12H18N2OS3 Reagent|High-Purity|RUO | High-purity C12H18N2OS3 for laboratory research. For Research Use Only (RUO). Not for diagnostic, therapeutic, or personal use. |
What is Materials Synthesis and why is optimizing conditions like temperature and precursor amounts critical for my feasibility research?
Materials synthesis is the process of creating new materials with desired properties by combining different substances in specific ways [59]. In the context of your thesis on synthesis feasibility, moving from a simple proof-of-concept to a reproducible, scalable, and efficient process is paramount. Optimization of parameters such as precursors, temperature, and reaction time is the key to this transition. It allows you to systematically understand how these factors influence the final material's properties, maximize yield and purity, and ensure the process is robust and economically viable for potential applications, such as in drug development or advanced materials [59] [60].
Traditional, intuition-guided "One Factor At a Time" (OFAT) optimization, where only one variable is changed while others are held constant, is often inaccurate and inefficient [61] [60]. This approach fails to account for synergistic effects between variables (e.g., how the ideal temperature might depend on the precursor concentration) and can miss the true optimal conditions within the complex parameter space of a chemical reaction [60].
Modern optimization strategies outperform human intuition by using model-based and algorithmic approaches. The table below summarizes the core methodologies available.
Table 1: Overview of Modern Reaction Optimization Techniques
| Method | Key Principle | Advantages | Best Use Cases |
|---|---|---|---|
| One Factor At a Time (OFAT) [61] [60] | Iteratively changes one variable while fixing all others. | Simple to plan and execute without specialized software or training. | Quick, initial exploratory tests; when a single, dominant variable is known. |
| Design of Experiments (DoE) [61] [60] | Uses statistical models to explore multiple factors and their interactions simultaneously with a structured set of experiments. | Efficient; reveals variable interactions; robust; identifies true optimum. | Screening multiple variables, rigorous optimization, and robustness testing for scale-up. |
| Kinetic Modeling [61] | Constructs a mechanistic model to understand the reaction process. | Provides deep fundamental understanding of the reaction pathway. | When reaction mechanism is of primary interest; for process intensification. |
| Self-Optimization [61] | Uses an optimization algorithm, automated reactor, and analysis in an iterative, closed-loop system. | Fully automated; fast; minimizes researcher time and material use. | For flow chemistry systems; when a well-defined objective exists (e.g., max yield). |
| Machine Learning (ML) [61] [62] | Uses high-quality historical data to train models that predict optimal reaction conditions. | Can uncover complex, non-obvious patterns; high prediction potential. | Leveraging large datasets; high-throughput experimentation (HTE); inverse design. |
The following workflow diagram illustrates how these different methodologies can be integrated into a comprehensive optimization campaign for your research.
Even with a well-designed plan, experiments can fail. A systematic approach to troubleshooting is a vital skill for any researcher [63].
Table 2: Systematic Troubleshooting Steps for Failed Synthesis
| Step | Action | Example: No PCR Product [63] | Example: Failed Chemical Reaction |
|---|---|---|---|
| 1. Identify | Clearly define the problem without assuming the cause. | "No PCR product is detected on the gel." | "Reaction yield is consistently low." |
| 2. Hypothesize | List all possible causes, from obvious to subtle. | Faulty Taq polymerase, degraded primers, incorrect Mg²⺠concentration, bad DNA template, faulty thermocycler. | Impure precursors, incorrect temperature, wrong stoichiometry, solvent issues, catalyst deactivation, moisture/oxygen sensitivity. |
| 3. Investigate | Collect data on the easiest explanations first. Review controls, storage conditions, and procedure. | Check positive control. Confirm kit storage. Review notebook for procedure errors. | Check analytics (NMR, LCMS). Verify precursor purity and concentration. Confirm reactor calibration (temperature). |
| 4. Eliminate | Rule out causes based on your investigation. | Positive control worked & kit was stored correctly â eliminate kit. No procedure errors â eliminate protocol. | Analytics show correct product but low yield â eliminate mechanism. Precursors are pure â eliminate purity. |
| 5. Experiment | Design tests for remaining potential causes. | Test DNA template integrity on a gel and measure concentration. | Systematically vary one suspected factor (e.g., temperature) in a controlled series. |
| 6. Resolve | Identify the root cause and implement a fix. | DNA template was degraded. Prepare a new, high-quality template. | Reaction was sensitive to moisture. Use dried solvents and an inert atmosphere. |
The logical flow of this troubleshooting process is visualized below.
Problem: Low Product Yield or Conversion
Problem: Poor Product Purity or Unwanted Byproducts
Problem: Irreproducible Results
Q1: I'm new to this. Why shouldn't I just use the simple OFAT method? OFAT is a logical starting point but has major limitations. It ignores interactions between factors. For example, the ideal temperature might be different for various precursor concentrations. OFAT often misidentifies the true optimum and is inefficient, requiring more experiments to gain less information than modern methods like DoE [60].
Q2: My reaction works, but the yield is inconsistent. Where should I focus my optimization? Start with the factors known to have the greatest impact: precursor quality and stoichiometry, followed by temperature control. Inconsistent yields are frequently traced to small variations in the purity or amount of a key precursor, or to uneven heating/cooling in the reaction vessel [63].
Q3: How do techniques like Machine Learning fit into a practical lab setting? Machine Learning (ML) models predict optimal conditions by learning from large, high-quality datasets, including those from High-Throughput Experimentation (HTE) [61]. While setting up a full ML workflow can be complex, ready-made software and databases are becoming more accessible. The current state is one of collaboration, where data from chemists fuels models that can then suggest promising conditions to test, greatly increasing synthetic efficiency [61] [62].
Q4: What does "green chemistry" have to do with optimization? Optimization is central to green chemistry. By optimizing precursors, temperature, and time, you can minimize energy consumption, reduce or eliminate hazardous waste, and improve atom economy. This leads to more sustainable and environmentally friendly processes, which is a critical consideration in modern industrial drug development and materials science [62] [66].
Q5: Can optimization for a small-scale lab reaction really help with large-scale production? Absolutely. In fact, that is one of its primary goals. Techniques like DoE explicitly include robustness testing, which determines how sensitive your reaction is to small, inevitable variations in conditions (e.g., ±2°C temperature fluctuation). A process that is robust at the lab scale has a much higher probability of successful and predictable scale-up to production [60].
This protocol exemplifies the precise optimization of precursor type, ratio, and heating method [64].
1. Objective: To synthesize ceramic-grade thoria powder via combustion synthesis using thorium nitrate and citric acid/urea as fuels. 2. Precursors: * Oxidant: Thorium nitrate (Th(NOâ)â). * Fuel: Citric acid (CâHâOâ) or Urea (CHâNâO). 3. Methodology: * Prepare aqueous solutions of thorium nitrate and the fuel. * Mix the solutions in a defined fuel-to-nitrate ratio. The study found a citric acid/nitrate ratio of â¥1 was optimal [64]. * Heating: Heat the mixture on a hotplate until the solution undergoes combustion, forming a solid foam. (Note: Microwave heating was found to be less effective for complete combustion in this specific case) [64]. * Calcination: Transfer the resulting solid powder to a furnace and calcine in air at 1073 K (800 °C) for 4 hours to obtain the final crystalline ThOâ product. 4. Key Optimization Insight: The choice of fuel and its ratio to the metal oxidizer is critical. This ratio determines the exothermicity of the reaction (the "propagating front") and the nature of the gaseous products, which ultimately controls the porosity and surface area of the final oxide powder [64].
Table 3: Exemplar Optimization Data from a Model SNAr Reaction using DoE [60]
| Experiment ID | Residence Time (min) | Temperature (°C) | Pyrrolidine (equiv.) | Yield of Product 7 (%) |
|---|---|---|---|---|
| 1 | 0.5 | 30 | 2 | [Value] |
| 2 | 3.5 | 30 | 2 | [Value] |
| 3 | 0.5 | 70 | 2 | [Value] |
| 4 | 3.5 | 70 | 2 | [Value] |
| 5 | 0.5 | 30 | 10 | [Value] |
| ... | ... | ... | ... | ... |
| Center Point | 2.0 | 50 | 6 | [Average Yield] |
| Optimum (Predicted) | ~2.5 | ~65 | ~8.5 | >90% (Predicted) |
Table 4: Optimal Parameters for Heat and Mass Transfer[a] from a Computational Study [65]
| Optimization Goal | Heat Source | Diffusivity | Inner Vessel Diameter |
|---|---|---|---|
| Best Efficiency in Temperature & Concentration Parameters | 2.555° | 0.025 | 3.144 cm |
| [a] As identified by Response Surface Methodology (RSM). |
Table 5: Essential Reagents and Materials for Synthesis Optimization
| Reagent/Material | Function in Optimization | Key Considerations |
|---|---|---|
| High-Purity Precursors | Starting materials for the reaction; purity is paramount for reproducibility and accurate yield calculation. | Verify purity via certificate of analysis (CoA); use consistent supplier; store under recommended conditions. |
| Fuels (e.g., Urea, Citric Acid) | In combustion synthesis, they react exothermically with metal nitrates to form the desired oxide [64]. | The fuel/oxidizer ratio is a critical optimization parameter that controls reaction violence and product morphology. |
| Statistical Software (JMP, Design-Expert, MODDE) | To design efficient experiments (DoE) and build models relating process factors to outputs (yield, purity) [61] [60]. | Reduces the total number of experiments needed to find an optimum; essential for understanding complex interactions. |
| Automated Reactor Systems | Enables self-optimization by automatically adjusting parameters (temp, flow rate) and analyzing output in a closed loop [61]. | Drastically reduces researcher time and material usage for optimization; excellent for flow chemistry. |
| Calibrated Analytical Equipment | For precise measurement of precursors (balances) and accurate temperature control (thermocouples, Peltier blocks). | Foundational for any reproducible experimental work. Regular calibration is non-negotiable. |
What is a metastable material? A metastable material is a non-equilibrium state of matter that possesses a Gibbs free energy higher than the most stable state (ground state) but remains in a state of internal equilibrium for a prolonged period. It is trapped in a local energy minimum on the potential energy surface, separated from the global minimum by an energy barrier [67] [68].
Why are metastable materials important for research and technology? Metastable phases often exhibit physical and chemical properties that are superior to their stable counterparts, making them invaluable for various technological applications. Their unique functionality is exploited in areas such as next-generation electronic devices, high-performance catalysts for clean energy, biomedical imaging, and neutron absorbers in nuclear reactors [68] [69] [70].
What is the "metastability threshold"? The metastability threshold refers to the excess energy stored in a metastable phase relative to its ground state. It quantifies the degree of metastability and provides insight into the amount of energy required to form and stabilize a specific metastable phase. Calculating this threshold can help predict which metastable phases are experimentally accessible [68].
Which synthesis method should I choose to achieve a high cooling rate? Rapid liquid quenching is a premier method for achieving high cooling rates. The rate is governed by sample dimensions, material heat conduction, and heat transfer rate to the quenching medium. By flattening a liquid into a thin sheet against a solid heat sink, cooling rates of 10^5 to 10^6 K/s are common. Ultra-short pulsed laser melting can achieve even higher rates, up to 10^14 K/s [67].
How can I synthesize metastable 2D materials, like specific TMD phases? Metastable metallic (1T/1T') phases of 2D Transition Metal Dichalcogenides (TMDs) require careful phase control. Bottom-up vapour- and liquid-phase synthesis methods can be designed to directly form these phases. Key strategies involve destabilizing the stable 2H phase through external means like charge transfer or by creating specific chemical environments that favor the metastable phase's nucleation and growth [71].
My target metastable phase is not forming via conventional heating. What are my alternatives? Solid-state processing methods that utilize mechanical deformation, such as High-Energy Ball Milling (HEBM), are excellent alternatives. HEBM introduces a high density of defects and creates highly transient pressure and temperature conditions, allowing the formation of metastable phases that cannot be recovered from conventional high-pressure and high-temperature experiments [67] [69].
| Potential Cause | Diagnostic Steps | Recommended Solution |
|---|---|---|
| Insufficient driving force/energy input. | Check if the energy input (e.g., quenching rate, mechanical energy) surpasses the metastability threshold of the target phase [68]. | Increase the driving force (e.g., higher laser power for melting, faster quenching speed, longer milling time in HEBM). |
| Unoptimized reaction environment. | For 2D materials, analyze the chemical environment (e.g., alkali concentration) and precursors [70]. | For molten-alkali synthesis, ensure a strong alkali environment (e.g., excess KOH) and suitable precursors [70]. |
| Kinetic barriers are too high. | Consult computational models or literature on phase transformation kinetics. | Introduce catalysts or mineralizers to lower energy barriers. Apply a different synthesis route (e.g., HEBM or irradiation) that directly injects energy [67] [69]. |
| The phase is thermodynamically inaccessible. | Calculate the phase's energy above the convex hull (metastability threshold). A very high value may indicate impractical synthesis [68] [72]. | Re-evaluate the target material system; a different metastable phase with a lower threshold might be more feasible. |
| Potential Cause | Diagnostic Steps | Recommended Solution |
|---|---|---|
| Competing phase formation. | Use in situ characterization (e.g., XRD) to monitor phase evolution during synthesis [22] [73]. | Precisely control cooling rates or reaction times to bypass the nucleation zone of competing phases. Modify precursor chemistry. |
| Insufficient reaction completeness. | Check for unreacted starting materials in the final product with XRD or spectroscopy. | In HEBM, optimize parameters like milling speed, time, and ball-to-powder ratio for a more complete reaction [69]. |
| Contamination from synthesis media. | Analyze the final product for impurities from grinding media (HEBM) or containers (molten alkali). | Use hardened or lined milling media. For molten-alkali methods, ensure container material is chemically inert. |
| Potential Cause | Diagnostic Steps | Recommended Solution |
|---|---|---|
| Kinetic persistence is too low. | The phase rapidly transforms to a more stable state upon returning to ambient conditions. | Design the synthesis to create "internal frustration"âcompeting internal phases or defects that block transformation pathways, kinetically trapping the metastable phase [73]. |
| Residual stresses induce transformation. | Characterize the material for microstrain and defect density. | Perform a post-synthesis annealing step at a carefully controlled temperature to relieve stress without triggering phase transformation. |
Objective: To synthesize metastable-phase 2D noble-metal oxides (e.g., 1T-IrO2, 1T-RhO2) using a combination of chemical and mechanical energy.
Materials:
Procedure:
Objective: To produce bulk metastable ceramic materials through severe mechanical deformation.
Materials:
Procedure:
Objective: To induce a metastable supercrystal phase in a layered ferroelectric/non-ferroelectric heterostructure.
Materials:
Procedure:
Table 1: Comparison of Key Metastable Material Synthesis Methods
| Method | Typical Form/Product | Key Controlling Parameters | Approximate Quenching/Energy Rate | Metastability Source |
|---|---|---|---|---|
| Rapid Liquid Quenching [67] | Ribbons, wires, thin films | Cooling medium, sample thickness, interface velocity | 10^5 - 10^6 K/s (up to 10^14 K/s with ultra-short pulses) | Compositional, Morphological |
| High-Energy Ball Milling (HEBM) [67] [69] | Powdered alloys, ceramics | Milling speed/duration, ball-to-powder ratio, chemical environment | Not directly measured (high transient T & P) | Defect concentration, Morphological |
| Laser-Induced Metastability [73] | Thin films, supercrystals | Laser fluence, pulse duration, number of pulses, sample frustration | Ultra-fast (femtosecond-scale excitation) | Morphological, compositional (via photocarriers) |
| Vapor Phase Condensation [67] | Thin films | Vapor pressure, substrate temperature, deposition rate | ~10^12 K/s | Compositional, Metastable phases |
| Molten-Alkali Mechanochemical [70] | 2D nanosheets (e.g., 1T-IrO2) | Alkali concentration, mechanical force, precursor | Combines chemical and mechanical energy | Metastable phases (crystalline structure) |
Table 2: Research Reagent Solutions for Metastable Material Synthesis
| Reagent / Material | Function / Role in Synthesis | Example Application |
|---|---|---|
| Potassium Hydroxide (KOH) | Creates a strong alkali environment that facilitates the formation and stabilization of 2D layered structures and specific metastable phases [70]. | Molten-alkali synthesis of 1T-phase IrO2 and RhO2 nanosheets [70]. |
| Precursor Salts (e.g., KNO3) | Acts as an oxidant during the pre-treatment step to form a specific precursor oxide that is more amenable to the subsequent mechanochemical reaction [70]. | Pre-forming a precursor oxide for molten-alkali synthesis [70]. |
| Zirconia/Tungsten Carbide Milling Balls | The grinding media in HEBM that impart mechanical energy through impacts, causing severe plastic deformation, fracturing, and cold welding of powders [69]. | Synthesis of metastable oxide ceramics via solid-state reaction induced by mechanical force [69]. |
| Noble Metal Powders (Ru, Ir, Rh) | The primary metallic precursors for synthesizing noble-metal oxides with metastable crystal structures and enhanced catalytic properties [70]. | Base material for creating metastable 2D noble-metal oxide catalysts [70]. |
Transitioning a process from laboratory-scale experiments to full-scale production is a critical phase in research and development, particularly when identifying materials with high synthesis feasibility. This guide provides targeted troubleshooting and FAQs to help researchers, scientists, and drug development professionals navigate the common volume and cost challenges encountered during scale-up.
Problem: The final product's properties (e.g., texture, viscosity, stability) are not consistent when produced at a larger scale compared to the lab-scale product [74].
Problem: The cost of production at scale is not economically viable [75].
Problem: A process that worked perfectly at the bench fails or yields a different product when transferred to production equipment [75] [74].
Q1: What are the most common technical mistakes when scaling up a mixing or reaction process? A: The most common mistake is assuming the process will scale linearly. Critical parameters that often require recalibration include [74]:
Q2: How can I accurately predict the cost of scaling up my synthesis process? A: A detailed economic analysis is crucial. Key cost components to evaluate include [75]:
Q3: Why is a small-scale "feasible" synthesis sometimes not feasible at a larger scale? A: Several factors can impact feasibility at scale [1]:
Q4: How do regulatory requirements impact the scale-up process? A: Regulatory compliance is a critical factor, especially in pharmaceuticals. The process must be validated every time it is scaled up by a factor of 10 or more. This involves rigorous quality assurance and control procedures to ensure the final product meets all specifications and standards, which may require additional testing and validation [76] [75].
The table below summarizes common scaling ratios and their primary cost drivers, based on industry guidelines [76] [75].
| Scale Transition | Typical Batch Size Increase | Primary Cost Drivers | Key Feasibility Considerations |
|---|---|---|---|
| Lab to Pilot | 10x | Pilot equipment, process optimization labor, initial quality control testing. | Process parameter refinement, identification of Critical Process Parameters (CPPs) [76]. |
| Pilot to Production | 10x - 100x | Capital for production equipment, raw material bulk purchasing, validation & regulatory compliance [75]. | Equipment design robustness, economic viability, stringent quality control to meet regulatory standards [75] [76]. |
Objective: To validate and refine process parameters before full-scale production. Methodology [75] [74] [76]:
The table below details key solutions and equipment critical for successful scale-up activities.
| Tool / Solution | Function in Scale-Up |
|---|---|
| Pilot Plant Systems | Serves as an intermediary step to refine process parameters (temperature, pressure, mixing rates) and collect valuable data before full-scale commitment [75]. |
| Scalable Lab System (SLS) / Milling Platforms | Provides a laboratory platform with interchangeable heads to determine the optimal size reduction technology, ensuring a smooth and predictable scale-up to production milling equipment [76]. |
| Vacuum Emulsifying Mixers | Industrial mixing equipment designed for the production of creams, ointments, and emulsions at scale, often incorporating vacuum to remove air bubbles [74]. |
| Industrial Homogenizers | Used for particle size reduction and ensuring emulsion stability in large-volume batches [74]. |
| NNAA-Synth (Cheminformatics Tool) | A specialized tool that plans and evaluates the synthesis of non-natural amino acids, integrating protection group strategies and feasibility scoring to bridge in-silico design and chemical synthesis [14]. |
| Automated Parts Washers | Provide consistent and validated cleaning of equipment parts with reduced variability compared to manual cleaning, which is critical for cGMP compliance in pharmaceutical production [77]. |
Table 1: Troubleshooting Common Automation Challenges
| Problem Area | Specific Issue | Potential Causes | Recommended Solutions |
|---|---|---|---|
| Data Quality | High rate of false positives/negatives [78] | Human error; assay variability; improper liquid handling [78] | Implement automated liquid handlers with verification (e.g., DropDetection); standardize protocols across users and sites [78] |
| Poor reproducibility between users or runs [78] | Inter- or intra-user variability; lack of standardized processes [78] | Integrate automation to streamline workflows and reduce manual intervention [78] | |
| Liquid Handling | Inconsistent dispensing volumes [78] | Instrument calibration drift; tip wear; viscous reagents | Use non-contact dispensers with in-built volume verification; schedule regular preventive maintenance |
| Sample & Data Tracking | Inability to uniquely identify samples or trace history [79] | Identical IDs for the same material across different plates or experiments [79] | Implement a nested sample structure with parent-child links for full traceability; use a LIMS [79] |
| Process & Workflow | Difficulty adding new experimental steps [79] | Inflexible sample tracking schema or data architecture [79] | Design system with flexibility principle; use abstract entities (e.g., ht_blob for biological objects) [79] |
| Throughput & Efficiency | Screening process is too slow for large compound libraries [78] | Manual processes; inefficient data analysis [78] | Employ automated systems for parallel processing; automate data management and analytical pipelines [78] |
Q1: What are the primary benefits of automating a high-throughput screening workflow? Automation significantly enhances data quality and reproducibility by standardizing workflows and reducing human error and variability [78]. It also increases throughput and efficiency, allows for miniaturization and cost reduction (up to 90% in some cases), and streamlines the management and analysis of vast multiparametric data sets [78].
Q2: Our HTS workflow is constantly evolving. How can we design an automation system that is flexible? The key is to adopt a schema that abstracts core components. For instance, separate the DNA, the protein, and the production machinery into distinct entities [79]. This allows you to add new experimental steps or change protocols without breaking the entire tracking system. Implement a parent-child sample relationship in your Laboratory Information Management System (LIMS) to maintain traceability even when workflows branch or change [79].
Q3: Our machine learning models require high-quality data. How does automation contribute to this? Robust sample tracking is the foundation. By ensuring that every piece of data is unambiguously linked to its corresponding sample and processing history, automation provides the clean, reliable data essential for training accurate ML models [79]. This is especially critical in multi-property optimization, where assays are performed at different stages and must be correctly correlated [79].
Q4: We have issues with sample identification across multiple experiments. What is the best practice? You need a system that generates unique identifiers for each physical sample instance, not just for the material. A powerful method is to use a nested sample structure where transferring a sample to a new container creates a new "child" sample with a unique ID, linked to its "parent." This builds a complete tree structure of the sample's journey, eliminating ambiguity about its origin [79].
Q5: What should we consider when selecting an automated liquid handler? Assess your specific needs in terms of scale and workflow flexibility [78]. Key considerations include precision at low volumes (e.g., for miniaturization), ability to be integrated into larger automated work cells, and the availability of features like in-built dispensing verification to support troubleshooting [78]. Also, evaluate the technical support, ease of use, and software integration [78].
Q6: How can we effectively manage and analyze the large volumes of data produced by HTS? Automate your data management and analytical processes [78]. This involves using integrated software platforms that can handle multiparametric data, allowing for automated hit identification and streamlined analysis to accelerate the time from experiment to insight [78].
This protocol outlines a method for establishing a flexible and traceable sample tracking system using a LIMS, based on principles proven in high-throughput protein engineering [79].
Key Reagent Solutions
| Item | Function in the Protocol |
|---|---|
| Laboratory Information Management System (LIMS) | Centralized platform for managing the complex web of sample information, metadata, and results. Serves as the digital backbone for traceability [79]. |
Entity Types (e.g., ht_prot, ht_blob) |
Data schemas that abstract key biological components (e.g., protein sequence, expression machinery). This abstraction enables workflow flexibility [79]. |
| Parent-Child Sample Links | A data field that links a new sample to its direct predecessor, creating a nested tree structure that allows for complete historical traceability [79]. |
| Calculated Fields in LIMS | Fields (e.g., resolved_protein) that automatically pull information from a parent or grandparent entity, adhering to the "Don't Repeat Yourself" principle and preventing data ambiguity [79]. |
Detailed Methodology:
ht_prot: Represents the protein or material design.ht_vect: Stores DNA sequence or construct information.ht_blob (Biological Little Object): Represents anything that generates your material (e.g., a cell strain, a reaction mixture) and links to the relevant ht_prot and ht_vect [79].ht_sample entity in the LIMS. This entity links to its corresponding ht_blob and contains calculated fields to resolve the final material of interest [79].ht_sample with a unique ID whenever you transfer material to a new plate or perform a QC analysis. Critically, populate the parent_sample field of this new sample to link it back to the sample it was derived from [79].
Q: My AI-planned synthetic route has a low step count but still seems inefficient. What other quantitative metrics can I use for a fuller assessment?
A: Step count is a common but incomplete metric. A comprehensive assessment should integrate multiple quantitative dimensions. The table below summarizes key metrics beyond step count.
| Metric | Description | Calculation | Ideal Value |
|---|---|---|---|
| Step Economy [80] | Count of steps in the longest linear sequence (LLS) or total steps. | Manual count from starting materials to target. | Lower is better. |
| Overall Yield [81] | Total yield of the multi-step sequence. | (Yieldâ Ã Yieldâ Ã ... Ã Yieldâ) Ã 100% | Higher is better. |
| Atom Economy [82] | Efficiency in incorporating reactant atoms into the final product. | (MW of Product / Σ MW of Reactants) à 100% | Higher is better. |
| Process Mass Intensity (PMI) [82] | Total mass used per unit mass of product, indicating environmental impact. | Total Mass in All Steps / Mass of Final Product | Lower is better. |
| Route Similarity Score [81] | Quantifies strategic overlap between two routes to the same target. | Geometric mean of atom (Satom) and bond (Sbond) similarity. Stotal = â(Satom à S_bond) | 0 to 1; higher score indicates greater similarity. |
Q: How can I objectively compare the strategic similarity of two different routes to the same molecule?
A: You can use a recently developed similarity score that combines atom and bond analysis [81]. This method requires atom-to-atom mapping for all reactions in the routes.
rxnmapper to generate atom-to-atom mappings for each reaction in both synthetic routes. Ensure the atom mapping for the final target molecule is consistent between the two routes.
Q: My route uses protecting groups, which I know is non-ideal. Is there a way to quantify this inefficiency?
A: Yes, vector-based efficiency analysis using molecular similarity and complexity can quantify the impact of non-productive steps [82].
The following tools and resources are essential for implementing the quantitative route analysis methods described above.
| Tool / Resource | Function & Application |
|---|---|
| RDKit [82] | An open-source cheminformatics toolkit used to generate molecular fingerprints (e.g., Morgan fingerprints) and calculate molecular similarity and complexity metrics from SMILES strings. |
| rxnmapper [81] | A tool for accurate atom-to-atom mapping of chemical reactions, which is a critical prerequisite for calculating bond and atom similarity scores between synthetic routes. |
| AiZynthFinder [82] | A computer-assisted synthesis planning (CASP) tool that uses a retrosynthetic approach to generate synthetic routes. Its output can be evaluated using the described metrics. |
| FAIR Data Principles [80] | A set of principles (Findable, Accessible, Interoperable, Reusable) for scientific data management. Adhering to these when documenting reactions is crucial for building robust predictive models. |
| Chemical Inventory Management System [80] | A sophisticated software system used in pharmaceutical companies for real-time tracking, secure storage, and regulatory compliance of building blocks and reagents, impacting cost and sourcing speed. |
Issue: Low Similarity Scores Between Chemically Intuitive Routes Problem: The calculated similarity score is low for two routes that experienced chemists judge to be very similar.
Issue: Inconsistent Scores When Comparing Multiple Routes Problem: When comparing Route A to B, and B to C, the scores do not provide a consistent basis for ranking all routes.
Issue: Metric Fails for Routes with Protective Group Strategies Problem: The similarity score does not adequately account for the use of protective groups, potentially rating a protected and deprotected step as entirely different.
Q1: What is the core principle behind this similarity metric? This metric calculates a similarity score between two synthetic routes to the same target molecule based on two key concepts: the set of bonds formed during the synthesis, and how the atoms of the final compound are grouped together throughout the synthetic process [83] [84].
Q2: When should I use this metric instead of traditional evaluation methods? This metric is particularly valuable for small datasets (fewer than 100 routes) where you want to assess the degree of similarity between routes. Traditional top-N accuracy used for large datasets only checks for an exact match, which is often too strict for practical evaluation [83].
Q3: How does this metric align with chemical intuition? The scoring method is designed to overlap well with chemists' intuition. Routes that form the same key bonds and assemble the molecule from similar intermediate fragments will receive a higher similarity score [84].
Q4: Can the metric compare routes of different lengths? Yes, the metric can be applied to routes with a different number of steps. The calculation inherently normalizes for this by focusing on the fundamental constructs of bond formation and atom grouping in the target molecule.
Q5: What are the inputs required to calculate the similarity score? The algorithm requires the complete synthetic pathways for the two routes being compared, including the structural information for all intermediates leading to the final target compound.
Objective: To quantitatively determine the similarity between two synthetic routes (Route A and Route B) to a given target molecule.
Materials:
Methodology:
Score Calculation: The algorithm computes the similarity score (S_total) by combining two component scores:
S_bonds): Calculates the similarity between the two "bonds formed" lists from Route A and Route B.S_grouping): Calculates the similarity between the atom grouping patterns throughout the two syntheses.Score Aggregation: The final similarity score is a weighted or combined function of S_bonds and S_grouping. The exact combination formula is detailed in the original publication [83].
Interpretation: A score of 1.0 indicates identical routes, while a score of 0.0 indicates completely dissimilar routes. Scores in between provide a quantitative measure of their relatedness.
The following table summarizes the key quantitative aspects of the similarity metric for easy reference.
| Metric Component | Description | Data Type | Impact on Score |
|---|---|---|---|
Bonds Formed (S_bonds) |
The set of covalent bonds created during the synthesis [83]. | Binary (Bond Present/Absent) and Order | High: Directly reflects the core chemical transformations. |
Atom Grouping (S_grouping) |
How atoms of the target are clustered in intermediates [83]. | Molecular Fragmentation Pattern | High: Captures the strategic assembly of the molecule. |
| Route Length (Step Count) | Number of synthetic steps. | Integer | Indirect: Accounted for during the comparison of bonds and groupings. |
Overall Similarity (S_total) |
Final composite score between two routes [83]. | Float (0.0 to 1.0) | Primary Output: 1.0 = identical, 0.0 = dissimilar. |
| Reagent / Material | Function in Synthesis Feasibility Research |
|---|---|
| Retrosynthetic Planning Software | Generates potential synthetic routes for a target molecule, providing the initial candidate set for feasibility analysis and comparison. |
| Cheminformatics Library (e.g., RDKit) | Provides the computational foundation for handling molecular structures, manipulating reactions, and calculating molecular descriptors essential for the similarity metric. |
| High-Throughput Experimentation (HTE) Kits | Allows for the rapid experimental validation of key synthetic steps predicted by algorithms, providing ground-truth data to assess and refine route predictions. |
| Similarity Metric Script | The core algorithm that performs the quantitative comparison between two synthetic routes based on bonds formed and atom groupings [83]. |
1. Why does my machine learning model perform well on the test set but fails to guide successful experimental synthesis? This common issue often stems from an "easy test set," where your validation data is enriched with straightforward problems that do not represent the true challenges encountered in real-world synthesis. When a model is validated on data that is too similar to its training set, its performance appears inflated, masking its failure to generalize to novel, complex materials. To address this, curate your validation set to include problems of various difficulty levels, particularly those with low similarity to your training data, to properly simulate experimental challenges [85].
2. How can I detect and prevent overfitting in my synthesis prediction models? Overfitting occurs when a model captures noise and specific patterns from the training data, leading to poor performance on new, unseen experimental data. Key indicators include high accuracy on your training set but significantly lower accuracy on your validation set. Mitigation strategies include:
3. What performance metrics should I use beyond simple accuracy? Relying solely on accuracy can be misleading, especially with imbalanced datasets common in materials research. A comprehensive validation requires multiple metrics [86] [85]:
4. What is data leakage, and how does it affect my synthesis feasibility predictions? Data leakage happens when information from the test or validation set inadvertently influences the model training process. This results in overly optimistic performance metrics that do not hold up in actual experiments. A classic example is including test data in the training set. To prevent this, strictly partition your data into training, validation, and test sets before any preprocessing, and ensure that the validation process only uses the designated datasets [86].
5. How can I ensure my model's predictions are relevant to my specific synthesis goals? Your model's validation must be aligned with your business and experimental objectives. This involves [86]:
Problem Your model accurately predicts the synthesis feasibility of materials similar to those in its training set but fails for novel compounds with low similarity (e.g., less than 30% sequence identity in protein prediction, analogous to new chemical spaces in materials science) [85].
Solution
Problem There is a significant gap between computationally screened "hits" and their successful synthesis and experimental validation in the lab [87].
Solution
Problem The model's predictions are skewed because the training data over-represents certain types of materials, leading to poor performance on underrepresented classes.
Solution
| Metric | Formula / Description | Interpretation in Synthesis Feasibility | Optimal Value |
|---|---|---|---|
| Accuracy | (TP+TN)/(TP+TN+FP+FN) | Overall correctness of feasibility predictions | Context-dependent, but high |
| Precision | TP/(TP+FP) | Proportion of predicted feasible syntheses that are actually feasible | High (minimize wasted resources) |
| Recall | TP/(TP+FN) | Proportion of actually feasible syntheses that were correctly predicted | High (avoid missing promising candidates) |
| F1 Score | 2(PrecisionRecall)/(Precision+Recall) | Harmonic mean of Precision and Recall | High (balanced view) |
| ROC-AUC | Area Under the ROC Curve | Model's ability to distinguish between feasible and infeasible synthesis | Close to 1.0 (excellent discrimination) |
TP: True Positives, TN: True Negatives, FP: False Positives, FN: False Negatives [86]
| Technique | Brief Description | Best Use Case in Synthesis Feasibility |
|---|---|---|
| Holdout Validation | Simple split into training and holdout (test) sets. | Initial model building with large datasets [86]. |
| K-Fold Cross-Validation | Data partitioned into K folds; each fold serves as a validation set once. | Robust performance estimation with limited data [86]. |
| Stratified K-Fold | Ensures each fold has a similar distribution of target classes. | Imbalanced datasets (e.g., few successful syntheses) [86]. |
| Bootstrap Methods | Creates multiple training sets by random sampling with replacement. | Assessing model stability and variance with limited data [86]. |
| Domain-Specific Validation | Uses industry-specific metrics and expert involvement. | High-stakes fields (e.g., healthcare, drug discovery) with regulatory requirements [86]. |
This protocol outlines the workflow for discovering new functional materials, such as magnetocaloric compounds for hydrogen liquefaction, by combining machine learning predictions with experimental synthesis and characterization [88].
Methodology:
This protocol ensures that a machine learning model performs reliably not just on average, but across problems of varying difficulty, which is critical for predicting the synthesis of novel materials [85].
Methodology:
ML-Experimental Validation Workflow
| Item / Solution | Function / Description | Example in Context |
|---|---|---|
| Orthogonal Protecting Groups | Enables selective deprotection of specific functional groups during synthesis, which is crucial for building complex molecules like non-natural amino acids (NNAAs). | Using Fmoc (base-labile) for the amino terminus and tBu (acid-labile) for the carboxyl terminus in peptide synthesis [14]. |
| Retrosynthetic Prediction Software | Proposes potential synthesis routes for a target molecule by breaking it down into simpler, available starting materials. | Tools like NNAA-Synth plan synthesis routes for individual NNAAs, evaluating steps and required reagents [14]. |
| Synthetic Feasibility Scorer | A deep learning-based tool that assesses the likelihood of success for a proposed synthetic route, often trained on reaction data. | Integrated within NNAA-Synth to score and rank proposed routes, prioritizing synthetically accessible building blocks [14]. |
| Domain-Specific Validation Frameworks | ML frameworks that incorporate expert-curated experimental data and chemistry-aware kernels to discover predictive descriptors. | The ME-AI (Materials Expert-AI) framework uses a Dirichlet-based Gaussian-process model to identify descriptors for topological materials [87]. |
The development of efficient and scalable synthesis routes for Active Pharmaceutical Ingredients (APIs) is a critical determinant of their viability and accessibility. Atorvastatin Calcium, a cornerstone in the management of dyslipidemia and prevention of cardiovascular disease, stands as a prime example [89]. As a blockbuster medication, the optimization of its production process holds significant economic and therapeutic importance [90]. This case study performs a comparative analysis of various Atorvastatin synthesis pathways, with the objective of identifying routes with high synthesis feasibility for research and development. The analysis is situated within a broader thesis on material identification, where synthesis feasibilityâencompassing yield, enantioselectivity, environmental impact, and operational complexityâis a key screening criterion for promising compounds.
Multiple synthetic strategies for Atorvastatin and its key intermediates have been developed, ranging from traditional chemical synthesis to modern biocatalytic and continuous manufacturing processes. The table below provides a quantitative comparison of the primary routes.
Table 1: Comparative Analysis of Atorvastatin Synthesis Routes
| Synthesis Route | Key Features | Reported Yield/ Productivity | Key Advantages | Key Challenges |
|---|---|---|---|---|
| Traditional Chemical Synthesis (Pfizer Route) | Paal-Knorr pyrrole synthesis; chiral side-chain installation [90]. | Not explicitly quantified in search results | Established, well-documented; versatile for analog design [90]. | Linear, long synthetic sequence; requires heavy metal catalysts (e.g., for Huisgen cycloaddition) [90]. |
| Biocatalytic (KRED/HHDH) Intermediate Synthesis | Two-step, three-enzyme system for chiral intermediate [91]. | High yield and enantiomeric excess (>99% ee) [91]. | High atom economy; low E-factor (minimal waste); excellent enantiocontrol [91]. | Requires enzyme optimization and cofactor regeneration systems. |
| DERA Aldolase-Catalyzed Side-Chain Synthesis | Double aldol addition using 2-deoxyribose-5-phosphate aldolase (DERA) [91]. | High productivity and selectivity [91]. | Catalytic, atom-economical method; enables one-pot sequential reactions [91]. | Potential for substrate inhibition; requires careful process control. |
| Continuous Manufacturing | Integrated, modular system combining reaction, crystallization, and agglomeration [91]. | Optimized for high throughput and yield [91]. | Enhanced product quality control; reduced manufacturing footprint; improved efficiency [91]. | High initial capital investment; requires advanced process control strategies. |
This protocol details the synthesis of a key chiral intermediate for Atorvastatin via a green biocatalytic process [91].
Principle: The process employs a ketoreductase (KRED) for enantioselective reduction and a halohydrin dehalogenase (HHDH) for cyanation, with cofactor regeneration.
Materials:
Procedure:
This protocol describes an advanced manufacturing technique for the final API, improving crystal properties and process efficiency [91].
Principle: An Oscillatory Baffled Crystallizer (COBC) provides superior control over supersaturation and temperature profiles compared to batch crystallizers, leading to consistent crystal size distribution.
Materials:
Procedure:
FAQ 1: What are the common solid-form issues encountered during Atorvastatin API development, and how can they be mitigated? Solid-form instability, such as the transformation of the desired crystalline form to an undesired polymorph during manufacturing or storage, is a common regulatory challenge [92]. These transformations can alter the drug's bioavailability and stability.
FAQ 2: Why is our biocatalytic process for the Atorvastatin side-chain showing decreased yield or selectivity over time? This is often due to enzyme denaturation or inactivation under process conditions.
FAQ 3: How can we improve the low yield in the Paal-Knorr pyrrole formation step of the traditional synthesis? The classic Paal-Knorr reaction can be sterically hindered for the synthesis of pentasubstituted pyrroles like the Atorvastatin core [90].
The following table lists key materials and reagents critical for the synthesis and analysis of Atorvastatin.
Table 2: Key Research Reagents and Materials for Atorvastatin Synthesis
| Reagent/Material | Function in Synthesis/Analysis | Key Considerations |
|---|---|---|
| Ketoreductase (KRED) | Biocatalyst for enantioselective reduction of a keto group to a chiral alcohol in the side-chain [91]. | Requires cofactor regeneration (NADPH); selection of specific KRED variant is critical for achieving high enantiomeric excess (>99% ee). |
| Halohydrin Dehalogenase (HHDH) | Biocatalyst for the conversion of a chloro-alcohol intermediate to a cyano-alcohol [91]. | Evolved enzyme variants offer higher productivity and stability; operates under mild aqueous conditions. |
| DERA (2-deoxyribose-5-phosphate aldolase) | Biocatalyst for a double aldol addition to construct the statin side-chain skeleton [91]. | Prone to substrate inhibition by acetaldehyde; use of engineered, resistant DERA variants is recommended. |
| Calcium Acetate | Salt used for the final formation of the stable Atorvastatin Calcium salt from the free acid form [91]. | Stoichiometry and purity are critical for achieving the correct polymorphic form and high API purity. |
| Reference Standards (Atorvastatin & Impurities) | Authentic chemical standards used for the identification and quantification of the API and its impurities during HPLC analysis [93]. | Essential for method validation and ensuring analytical accuracy according to ICH guidelines. |
| Zeolite Molecular Sieves | Solid acid catalysts used in certain chemical synthesis steps to improve yield and purity [91]. | Can be used to absorb water and drive reactions to completion; recyclable, making the process more economical. |
1. What are the most critical factors to assess when choosing a synthesis pathway?
When evaluating a synthesis pathway, three factors are paramount: thermodynamic feasibility, stoichiometric balance, and enzyme or precursor selection. Pathway design tools like novoStoic2.0 integrate these checks to ensure the designed route is energetically favorable, mass-balanced, and has known or engineerable catalysts for its reaction steps [94]. For solid-state materials synthesis, carefully selecting precursors to avoid stable, unreactive intermediates is equally critical [95].
2. How can I troubleshoot a pathway that is thermodynamically infeasible? If a pathway is thermodynamically unfavorable, consider these adjustments:
dGPredictor (integrated within novoStoic2.0) to calculate the standard Gibbs energy change (ÎG) for each reaction step. The steps with highly positive ÎG are the bottlenecks [94].SubNetX can help you find alternative, balanced branched pathways that may circumvent thermodynamically unfavorable steps by connecting to the host metabolism through multiple precursors [96].3. What should I do if no known enzyme exists for a novel reaction step in my pathway? For novel reaction steps, follow this troubleshooting guide:
EnzRank to screen existing enzyme sequences from databases (e.g., KEGG, Rhea) for potential activity with your novel substrate. It provides a probability score to rank-order the most compatible known enzymes for re-engineering [94].4. My solid-state synthesis consistently results in impurity phases. How can I improve phase purity?
Impurity formation is often due to unfavorable precursor reactions. The ARROWS3 algorithm addresses this by:
5. How do I select an optimal protection group strategy for Non-Natural Amino Acid (NNAA) synthesis?
For NNAAs destined for Solid-Phase Peptide Synthesis (SPPS), use a systematic tool like NNAA-Synth. It automates the selection of orthogonal protection groups [14]:
| Problem | Possible Cause | Diagnostic Steps | Solution |
|---|---|---|---|
| The calculated pathway is thermodynamically infeasible (overall ÎG > 0). | One or more reaction steps have a large, positive ÎG. | 1. Use dGPredictor or eQuilibrator to estimate ÎG for every step [94]. 2. Identify the step with the largest positive ÎG. |
1. Use a retrosynthesis tool (e.g., novoStoic, SubNetX) to find a pathway that bypasses this step [94] [96]. 2. Investigate if the reaction can be run in reverse as part of a different pathway. |
| Problem | Possible Cause | Diagnostic Steps | Solution |
|---|---|---|---|
| Low yield of the target material due to impurity phases. | Formation of stable, non-target intermediates that kinetically trap the reaction. | 1. Perform XRD on samples heated at different temperatures to identify intermediate phases [95]. 2. Use ARROWS3 to analyze which precursor pairs form these intermediates. |
1. Switch to precursor sets recommended by ARROWS3 that minimize the formation of these stable intermediates [95]. 2. Optimize heating profiles to avoid temperature zones where intermediates are most stable. |
Data sourced from pathway design tools like novoStoic2.0 and SubNetX [94] [96].
| Metric | Description | Ideal Value | Tool/Method for Estimation |
|---|---|---|---|
| Theoretical Yield | Maximum moles of target product per mole of primary substrate. | Maximized | optStoic [94] |
| Pathway Length | Number of enzymatic steps from primary substrate to target. | Minimized | novoStoic, SubNetX [94] [96] |
| Cofactor Usage | Total consumption of energy cofactors (e.g., ATP, NADPH). | Minimized | Stoichiometric analysis [94] |
| Thermodynamic Feasibility | Overall standard Gibbs energy change (ÎG) of the pathway. | < 0 (Negative) | dGPredictor, eQuilibrator [94] |
| Enzyme Availability | Number of novel reaction steps requiring enzyme engineering. | Minimized | EnzRank screening against KEGG/Rhea [94] |
Essential materials and their functions in computational and experimental synthesis validation.
| Reagent / Tool Category | Specific Example | Function in Synthesis Feasibility Research |
|---|---|---|
| Pathway Design Platform | novoStoic2.0 [94] |
Integrated web-based platform for de novo pathway design, thermodynamic analysis, and enzyme selection. |
| Retrosynthesis Algorithm | SubNetX [96] |
Extracts and assembles balanced, branched biochemical subnetworks from large reaction databases for complex molecules. |
| Precursor Selection Algorithm | ARROWS3 [95] |
Uses active learning and thermodynamics to autonomously select optimal solid-state precursors that avoid inert intermediates. |
| Gibbs Energy Estimator | dGPredictor [94] |
Estimates the standard Gibbs energy change (ÎG) for reactions, including those with novel metabolites. |
| Enzyme Selection Tool | EnzRank [94] |
Ranks known enzymes based on their predicted compatibility with a novel substrate, guiding protein re-engineering. |
| Orthogonal Protection Groups | Fmoc, tBu, Bn, PMB [14] | A set of mutually orthogonal chemical protecting groups for functional groups in NNAAs, enabling sequential deprotection during SPPS. |
Identifying materials with high synthesis feasibility is increasingly a multidisciplinary endeavor, successfully merging foundational physical chemistry with cutting-edge computational tools. The integration of machine learning and automation is poised to dramatically compress the materials discovery timeline, addressing urgent needs in drug development and other advanced industries. Future progress will depend on overcoming data scarcity, improving the prediction of kinetic pathways, and establishing robust validation frameworks. For biomedical research, these advancements promise not only faster discovery cycles but also the reliable synthesis of novel materials for drug delivery, diagnostics, and regenerative medicine, ultimately accelerating the translation of theoretical concepts into clinical applications.